Matthew J. Budoff MD

Matthew J. Budoff MD

University of California, Los Angeles

H-index: 159

North America-United States

Matthew J. Budoff MD Information

University

University of California, Los Angeles

Position

David Geffen School of Medicine at

Citations(all)

189834

Citations(since 2020)

81175

Cited By

130671

hIndex(all)

159

hIndex(since 2020)

111

i10Index(all)

1073

i10Index(since 2020)

824

Email

University Profile Page

University of California, Los Angeles

Matthew J. Budoff MD Skills & Research Interests

Cardiology

Atherosclerosis

Cardiac Imaging

Top articles of Matthew J. Budoff MD

Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial

Authors

Michael T Lu,Heather Ribaudo,Borek Foldyna,Markella V Zanni,Thomas Mayrhofer,Julia Karady,Jana Taron,Kathleen V Fitch,Sara McCallum,Tricia H Burdo,Kayla Paradis,Sandeep S Hedgire,Nandini M Meyersohn,Christopher DeFilippi,Carlos D Malvestutto,Audra Sturniolo,Marissa Diggs,Sue Siminski,Gerald S Bloomfield,Beverly Alston-Smith,Patrice Desvigne-Nickens,Edgar T Overton,Judith S Currier,Judith A Aberg,Carl J Fichtenbaum,Udo Hoffmann,Pamela S Douglas,Steven K Grinspoon,Eric S Daar,Babafemi Taiwo,Susan L Koletar,Kara W Chew,Susan J Little,Sonya L Heath,Jeffrey M Jacobson,Rajesh Gandhi,Gregory Robbins,Rachel M Presti,Marshall Glesby,Annie Luetkemeyer,Pablo Tebas,Sharon A Riddler,Michael P Dube,Jorge L Santana-Bagur,E Sha Beverly,Jennifer Manne,Roberto Arduino,Charles W Flexner,David W Haas,David A Wohl,Magdalena E Sobieszczyk,Karen T Tashima,Sonal S Munsiff,Rachel Bender Ignacio,Kristen Marks,Cornelius Van Dam,Shobha Swaminathan,Thomas B Campbell,Patricia Bandettini,Gerald Bloomfield,Judith Currier,Peter Kim,Heather J Ribaudo,Yves Rosenberg,James Troendle,Mark Byroads,Elaine Gershman,Folake Lawal,Jorge Leon-Cruz,Rochelle Louis,Cheryl Lowe,Eva Moy,Triin Umbleja,Namrata Upadhyay,Stephen Wiviott,Kenneth Wood,Oladapo Anthony,Radhika Barve,Fred Bone,Selina Bannoo,Annie Duffy,Carl Fletcher,Madison Green,Nory Klop-Packel,Emilia Norton,Jennifer Nowak,Maria Sanchez Grande,Eloise Walker,David Vlieg,Tricia Burdo,Laura Moran,Jhoanna Roa,Heather Sprenger,Bola Adedeji,Oladapo Alli,Blanca Castillo,Joan Dragavon,Keisha Easley,Julian Falutz,Ewelinka Grzejka,Erin Hoffman,Yuji Liao,Sara Looby,Dana Nohynek,Mary Pate,James Rooney,Akbar Shahkolahi,Craig Sponseller,Kenneth Williams,Markella Zanni,Kate Borloglou,Meredith Clement,Allison Eckard,Rebecca LeBlanc,Carlos Malvestutto,Edgar T Overton,Karl Shaw,Virginia Triant,Amy Kantor,Jennifer M Manne-Goehler,Kate Starr,Ronald Barnett,Jane Baum,Cindy Coates,Sandra W Cordoso,Christie Lyn Costanza,Sylvia Davila,Dushyantha Jayaweera,Teri Greenfield,Howard Gutzman,Regina Harden,Sarah Henn,MJ Humphries,Mamta Jain,David Klein,Sharon Kohrs,Javier Lama,Jessica Landis,Jaclyn Leone,Rita Lira,Maria Martinez,Richard Novak,Karen Reese,Breno Santos,Jenese Tucker,Aimee Wilkin,Tomeka Wilson,Barbara Bastow,Francoise Giguel,Nada Saleh

Journal

JAMA cardiology

Published Date

2024/2/21

ImportanceCardiovascular disease (CVD) is increased in people with HIV (PWH) and is characterized by premature noncalcified coronary plaque. In the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE), pitavastatin reduced major adverse cardiovascular events (MACE) by 35% over a median of 5.1 years.ObjectiveTo investigate the effects of pitavastatin on noncalcified coronary artery plaque by coronary computed tomography angiography (CTA) and on inflammatory biomarkers as potential mechanisms for MACE prevention.Design, Setting, and ParticipantsThis double-blind, placebo-controlled randomized clinical trial enrolled participants from April 2015 to February 2018 at 31 US clinical research sites.PWH without known CVD who were taking antiretroviral therapy and had low to moderate 10-year CVD risk were included. Data were analyzed from April to November 2023.InterventionOral …

Closing the Last Mile Gap in Access to Multimodality Imaging in Rural Settings: Design of the Imaging Core of the Risk Underlying Rural Areas Longitudinal Study

Authors

Hooman Fazlalizadeh,Muhammad Shahzeb Khan,Ervin R Fox,Pamela S Douglas,David Adams,Michael J Blaha,Melissa A Daubert,Gary Dunn,Edwin van den Heuvel,Michelle D Kelsey,Randolph P Martin,James D Thomas,Yngvil Thomas,Suzanne E Judd,Ramachandran S Vasan,Matthew J Budoff,Gerald S Bloomfield

Journal

Circulation: Cardiovascular Imaging

Published Date

2024/2

Achieving optimal cardiovascular health in rural populations can be challenging for several reasons including decreased access to care with limited availability of imaging modalities, specialist physicians, and other important health care team members. Therefore, innovative solutions are needed to optimize health care and address cardiovascular health disparities in rural areas. Mobile examination units can bring imaging technology to underserved or remote communities with limited access to health care services. Mobile examination units can be equipped with a wide array of assessment tools and multiple imaging modalities such as computed tomography scanning and echocardiography. The detailed structural assessment of cardiovascular and lung pathology, as well as the detection of extracardiac pathology afforded by computed tomography imaging combined with the functional and hemodynamic …

Social disadvantage, coronary artery calcium, and their interplay in the prediction of atherosclerotic cardiovascular disease events

Authors

Isaac Acquah,Miguel Cainzos-Achirica,Mohamad B Taha,Shubham Lahan,Michael J Blaha,Sadeer G Al-Kindi,Safi U Khan,Garima Sharma,Matthew J Budoff,Khurram Nasir

Journal

Atherosclerosis

Published Date

2023/10/25

Background and aimsSocial determinants of health (SDOH) are key for the identification of populations at increased risk of atherosclerotic cardiovascular disease (ASCVD). However, whether at the individual level SDOH improve current ASCVD risk prediction paradigms beyond traditional risk factors and the coronary artery calcium (CAC) score, is unknown. We evaluated the interplay between CAC and SDOH in ASCVD risk prediction.MethodsMESA is a prospective study of US adults free of clinical ASCVD at baseline. We used an SDOH index inclusive of 14 determinants from 5 domains. The index ranged 0–1 and was divided into quartiles, with higher ones representing worse SDOH. Cox regression was used to evaluate the adjusted associations between CAC, SDOH, their interplay, and ASCVD events. The C-statistic was computed to assess improvement in risk discrimination for prediction of ASCVD events …

The Impact of Semaglutide on Liver Fat Assessed by Serial Cardiac CT scans in Patients with Type 2 Diabetes: Results from STOP Trial

Authors

Venkat Sanjay Manubolu,April Kinninger,Jairo Aldana-Bitar,Keishi Ichikawa,Hooman Fazlalizadeh,Leili Pourafkari,Khadije Ahmad,Shriraj Susarla,Czarina Mangaoang,Ahmed K Ghanem,Denise Alison Javier,Sajad Hamal,Sion K Roy,Matthew J Budoff

Journal

American Heart Journal

Published Date

2024/1/1

IntroductionThere is increasing prevalence of hepatic steatosis. Hepatic steatosis is increasingly recognized as the independent risk factor for cardiovascular mortality. However, there are limited options for the treatment of fatty liver. In this study we evaluated the effect of semaglutide on liver fat as measured by non-contrast cardiac CT scans.MethodsSTOP is a randomized controlled trial that evaluated semaglutide treatment effect on coronary atherosclerosis progression (STOP) in type 2 diabetes. We utilized unenhanced cardiac CT scans to quantify liver fat based on CT Hounsfield attenuation method. A total of 114 subjects qualified for this study of the 140 subjects randomized, 59 in semaglutide group and 55 in the placebo group and were followed for 12 months. Multivariate regression models were used to evaluate the change in liver fat content overtime.Results114 subjects were included in the study, 61 …

Coronary artery calcium score predicts major adverse cardiovascular events in stable chest pain

Authors

Federico Biavati,Luca Saba,Melinda Boussoussou,Klaus F Kofoed,Theodora Benedek,Patrick Donnelly,José Rodríguez-Palomares,Andrejs Erglis,Cyril Štěchovský,Gintarė Šakalytė,Nada Čemerlić Ađić,Matthias Gutberlet,Jonathan D Dodd,Ignacio Diez,Gershan Davis,Elke Zimmermann,Cezary Kępka,Radosav Vidakovic,Marco Francone,Małgorzata Ilnicka-Suckiel,Fabian Plank,Juhani Knuuti,Rita Faria,Stephen Schröder,Colin Berry,Balazs Ruzsics,Nina Rieckmann,Christine Kubiak,Kristian Schultz Hansen,Jacqueline Müller-Nordhorn,Pál Maurovich-Horvat,Per E Sigvardsen,Imre Benedek,Clare Orr,Filipa Xavier Valente,Ligita Zvaigzne,Vojtěch Suchánek,Antanas Jankauskas,Filip Ađić,Michael Woinke,Diarmaid Cadogan,Iñigo Lecumberri,Erica Thwaite,Mariusz Kruk,Aleksandar N Neskovic,Massimo Mancone,Donata Kuśmierz,Gudrun Feuchtner,Mikko Pietilä,Vasco Gama Ribeiro,Tanja Drosch,Christian Delles,Riccardo Cau,Michael Fisher,Bela Merkely,Charlotte Kragelund,Rosca Aurelian,Stephanie Kelly,Bruno García del Blanco,Ainhoa Rubio,Bálint Szilveszter,Jens D Hove,Ioana Rodean,Susan Regan,Hug Cuéllar Calabria,István Ferenc Édes,Linnea Larsen,Roxana Hodas,Adriane E Napp,Robert Haase,Sarah Feger,Mahmoud Mohamed,Lina M Serna-Higuita,Konrad Neumann,Henryk Dreger,Matthias Rief,Viktoria Wieske,Matthew J Budoff,Melanie Estrella,Peter Martus,Maria Bosserdt,Marc Dewey,DISCHARGE Trial Group

Journal

Radiology

Published Date

2024/3/5

Background Coronary artery calcium (CAC) has prognostic value for major adverse cardiovascular events (MACE) in asymptomatic individuals, whereas its role in symptomatic patients is less clear. Purpose To assess the prognostic value of CAC scoring for MACE in participants with stable chest pain initially referred for invasive coronary angiography (ICA). Materials and Methods This prespecified subgroup analysis from the Diagnostic Imaging Strategies for Patients With Stable Chest Pain and Intermediate Risk of Coronary Artery Disease (DISCHARGE) trial, conducted between October 2015 and April 2019 across 26 centers in 16 countries, focused on adult …

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

Authors

Parminder K Judge,Natalie Staplin,Kaitlin J Mayne,Christoph Wanner,Jennifer B Green,Sibylle J Hauske,Jonathan R Emberson,David Preiss,Sarah YA Ng,Alistair J Roddick,Emily Sammons,Doreen Zhu,Michael Hill,Will Stevens,Karl Wallendszus,Susanne Brenner,AK Cheung,ZH Liu,J Li,LS Hooi,WJ Liu,T Kadowaki,M Nangaku,A Levin,D Cherney,AP Maggioni,R Pontremoli,R Deo,S Goto,X Rossello,KR Tuttle,D Steubl,D Massey,MJ Landray,C Baigent,R Haynes,WG Herrington,S Abat,R Abd Rahman,R Abdul Cader,MI Abdul Hafidz,MZ Abdul Wahab,NK Abdullah,T Abdul-Samad,M Abe,N Abraham,S Acheampong,P Achiri,JA Acosta,A Adeleke,V Adell,R Adewuyi-Dalton,N Adnan,A Africano,M Agharazii,F Aguilar,A Aguilera,M Ahmad,MK Ahmad,NA Ahmad,NH Ahmad,NI Ahmad,N Ahmad Miswan,H Ahmad Rosdi,I Ahmed,S Ahmed,J Aiello,A Aitken,R AitSadi,S Aker,S Akimoto,A Akinfolarin,S Akram,F Alberici,C Albert,L Aldrich,M Alegata,L Alexander,S Alfaress,M Alhadj Ali,A Ali,R Alicic,A Aliu,R Almaraz,R Almasarwah,J Almeida,A Aloisi,L Al-Rabadi,D Alscher,P Alvarez,B Al-Zeer,M Amat,C Ambrose,H Ammar,Y An,L Andriaccio,K Ansu,A Apostolidi,N Arai,H Araki,S Araki,A Arbi,O Arechiga,S Armstrong,T Arnold,S Aronoff,W Arriaga,J Arroyo,D Arteaga,S Asahara,A Asai,N Asai,S Asano,M Asawa,MF Asmee,F Aucella,M Augustin,A Avery,A Awad,IY Awang,M Awazawa,A Axler,W Ayub,Z Azhari,R Baccaro,C Badin,B Bagwell,E Bahlmann-Kroll,AZ Bahtar,D Bains,H Bajaj,R Baker,E Baldini,B Banas,D Banerjee,S Banno,S Bansal,S Barberi,S Barnes,C Barnini,C Barot,K Barrett,R Barrios,B Bartolomei Mecatti,I Barton,J Barton,W Basily,S Bavanandan,A Baxter,L Becker

Journal

The Lancet Diabetes & Endocrinology

Published Date

2024/1/1

BackgroundThe EMPA-KIDNEY trial showed that empagliflozin reduced the risk of the primary composite outcome of kidney disease progression or cardiovascular death in patients with chronic kidney disease mainly through slowing progression. We aimed to assess how effects of empagliflozin might differ by primary kidney disease across its broad population.MethodsEMPA-KIDNEY, a randomised, controlled, phase 3 trial, was conducted at 241 centres in eight countries (Canada, China, Germany, Italy, Japan, Malaysia, the UK, and the USA). Patients were eligible if their estimated glomerular filtration rate (eGFR) was 20 to less than 45 mL/min per 1·73 m2, or 45 to less than 90 mL/min per 1·73 m2 with a urinary albumin-to-creatinine ratio (uACR) of 200 mg/g or higher at screening. They were randomly assigned (1:1) to 10 mg oral empagliflozin once daily or matching placebo. Effects on kidney disease …

Prediction of the development of new coronary atherosclerotic plaques with radiomics

Authors

Sang-Eun Lee,Youngtaek Hong,Jongsoo Hong,Juyeong Jung,Ji Min Sung,Daniele Andreini,Mouaz H Al-Mallah,Matthew J Budoff,Filippo Cademartiri,Kavitha Chinnaiyan,Jung Hyun Choi,Eun Ju Chun,Edoardo Conte,Ilan Gottlieb,Martin Hadamitzky,Yong Jin Kim,Byoung Kwon Lee,Jonathon A Leipsic,Erica Maffei,Hugo Marques,Pedro de Araújo Gonçalves,Gianluca Pontone,Sanghoon Shin,Peter H Stone,Habib Samady,Renu Virmani,Jagat Narula,Leslee J Shaw,Jeroen J Bax,Fay Y Lin,James K Min,Hyuk-Jae Chang

Journal

Journal of Cardiovascular Computed Tomography

Published Date

2024/2/19

BackgroundRadiomics is expected to identify imaging features beyond the human eye. We investigated whether radiomics can identify coronary segments that will develop new atherosclerotic plaques on coronary computed tomography angiography (CCTA).MethodsFrom a prospective multinational registry of patients with serial CCTA studies at ≥ 2-year intervals, segments without identifiable coronary plaque at baseline were selected and radiomic features were extracted. Cox models using clinical risk factors (Model 1), radiomic features (Model 2) and both clinical risk factors and radiomic features (Model 3) were constructed to predict the development of a coronary plaque, defined as total PV ​≥ ​1 ​mm3, at follow-up CCTA in each segment.ResultsIn total, 9583 normal coronary segments were identified from 1162 patients (60.3 ​± ​9.2 years, 55.7% male) and divided 8:2 into training and test sets. At follow …

Nontraditional Risk Markers for Incident Coronary Artery Calcium Among Persons≥ 65 Years of Age

Authors

Alexander C Razavi,Omar Dzaye,Erin D Michos,Matthew J Budoff,Norrina B Allen,Joao AC Lima,Joseph F Polak,Wendy S Post,Khurram Nasir,Roger S Blumenthal,Laurence S Sperling,Michael J Blaha,Seamus P Whelton

Journal

JACC: Advances

Published Date

2024/2/1

Background The initiation of coronary artery calcium (CAC) is an important physiologic milestone associated with increased cardiovascular disease risk. However, traditional risk factors (RF) do not perform well for predicting incident CAC among the 54 million older U.S. adults. Objectives The authors sought to assess the association between nontraditional cardiovascular disease RF and incident CAC in older persons. Methods There were 815 MESA (Multi-Ethnic Study of Atherosclerosis) participants ≥65 years of age who had CAC = 0 at Visit 1 and a follow-up CAC scan. Multivariable adjusted Cox hazards ratios (aHR) and C-statistics were calculated to examine the association of nontraditional RF with incident CAC. Results The mean age was 70.2 years and 67% were women. The median follow-up time to repeat CAC scan was 3.6 years (IQR: 2.6-9.2 years) and 45% of participants developed incident CAC …

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the EMPA-KIDNEY trial

Authors

N Staplin,R Haynes,PK Judge,C Wanner,JB Green,J Emberson,D Preiss,KJ Mayne,SYA Ng,E Sammons,D Zhu,M Hill,W Stevens,K Wallendszus,S Brenner,AK Cheung,ZH Liu,J Li,LS Hooi,WJ Liu,T Kadowaki,M Nangaku,A Levin,D Cherney,AP Maggioni,R Pontremoli,R Deo,S Goto,X Rossello,KR Tuttle,D Steubl,M Petrini,S Seidi,MJ Landray,C Baigent,WG Herrington,S Abat,R Abd Rahman,R Abdul Cader,MI Abdul Hafidz,MZ Abdul Wahab,NK Abdullah,T Abdul-Samad,M Abe,N Abraham,S Acheampong,P Achiri,JA Acosta,A Adeleke,V Adell,R Adewuyi-Dalton,N Adnan,A Africano,M Agharazii,F Aguilar,A Aguilera,M Ahmad,MK Ahmad,NA Ahmad,NH Ahmad,NI Ahmad,N Ahmad Miswan,H Ahmad Rosdi,I Ahmed,S Ahmed,J Aiello,A Aitken,R AitSadi,S Aker,S Akimoto,A Akinfolarin,S Akram,F Alberici,C Albert,L Aldrich,M Alegata,L Alexander,S Alfaress,M Alhadj Ali,A Ali,R Alicic,A Aliu,R Almaraz,R Almasarwah,J Almeida,A Aloisi,L Al-Rabadi,D Alscher,P Alvarez,B Al-Zeer,M Amat,C Ambrose,H Ammar,Y An,L Andriaccio,K Ansu,A Apostolidi,N Arai,H Araki,S Araki,A Arbi,O Arechiga,S Armstrong,T Arnold,S Aronoff,W Arriaga,J Arroyo,D Arteaga,S Asahara,A Asai,N Asai,S Asano,M Asawa,MF Asmee,F Aucella,M Augustin,A Avery,A Awad,IY Awang,M Awazawa,A Axler,W Ayub,Z Azhari,R Baccaro,C Badin,B Bagwell,E Bahlmann-Kroll,AZ Bahtar,D Bains,H Bajaj,R Baker,E Baldini,B Banas,D Banerjee,S Banno,S Bansal,S Barberi,S Barnes,C Barnini,C Barot,K Barrett,R Barrios,B Bartolomei Mecatti,I Barton,J Barton,W Basily,S Bavanandan,A Baxter,L Becker,S Beddhu

Journal

The Lancet Diabetes & Endocrinology

Published Date

2024/1/1

BackgroundSodium–glucose co-transporter-2 (SGLT2) inhibitors reduce progression of chronic kidney disease and the risk of cardiovascular morbidity and mortality in a wide range of patients. However, their effects on kidney disease progression in some patients with chronic kidney disease are unclear because few clinical kidney outcomes occurred among such patients in the completed trials. In particular, some guidelines stratify their level of recommendation about who should be treated with SGLT2 inhibitors based on diabetes status and albuminuria. We aimed to assess the effects of empagliflozin on progression of chronic kidney disease both overall and among specific types of participants in the EMPA-KIDNEY trial.MethodsEMPA-KIDNEY, a randomised, controlled, phase 3 trial, was conducted at 241 centres in eight countries (Canada, China, Germany, Italy, Japan, Malaysia, the UK, and the USA), and …

Risk stratifying individuals with zero, minimal, and mild coronary artery calcium for cardiovascular disease by determining coronary plaque burden

Authors

Salman Ansari,Leili Pourafkari,April Kinninger,Venkat Manubolu,Matthew J Budoff

Journal

Journal of Cardiovascular Computed Tomography

Published Date

2024/3/1

Background and aimsUse of coronary artery calcium (CAC) continues to expand, and several different categories of risk have been developed. Some categorize CAC as <10, 11–100 and ​> ​100, while others use CAC ​= ​0,1–10, 11–100 and ​> ​100 as categories. We sought to evaluate the plaque burden in patients with CAC 0, 1–10 and 11–100 to evaluate the best use of CAC scoring for risk assessment.MethodsPatients were recruited from existing prospective CCTA trials with CAC scores ≤100 and quantitative coronary plaque analysis (QAngio, Medis). CAC was categorized into three groups: zero (CAC ​= ​0), minimal (CAC 1–10), and mild (CAC 11–100). Plaque levels (low attenuated, fibrous, fibro-fatty, dense calcified, total non-calcified) were assessed using multivariable linear regression adjusted for cardiovascular risk factors (age, ethnicity, BMI, gender, hypertension, dyslipidemia, diabetes …

Coronary artery calcium and cardiovascular outcomes in patients with lymphoma undergoing autologous hematopoietic cell transplantation

Authors

Stephanie Wu,June‐Wha Rhee,Aleksi Iukuridze,Alysia Bosworth,Sitong Chen,Liezl Atencio,Venkat Manubolu,Rusha Bhandari,Faizi Jamal,Matthew Mei,Alex Herrera,Fatima Rodriguez,Stephen Forman,Ryotaro Nakamura,F Lennie Wong,Matthew Budoff,Saro H Armenian

Journal

Cancer

Published Date

2024/2/15

Background Patients undergoing autologous hematopoietic cell transplantation (HCT) have a >2‐fold risk of developing cardiovascular disease (CVD; heart failure, myocardial infarction, and stroke), compared to the general population. Coronary artery calcium (CAC) is predictive of CVD in nononcology patients but is not as well studied in patients who underwent HCT and survivors of HCT.The objective of this study was to examine the association between CAC and CVD risk and outcomes after HCT in patients with lymphoma. Methods This was a retrospective cohort study of 243 consecutive patients who underwent a first autologous HCT for lymphoma between 2009 and 2014. CAC (Agatston score) was determined from chest computed tomography obtained <60 days from HCT. Multivariable Cox regression analysis was used to calculate hazard ratio (HR) estimates and 95% confidence intervals (CIs …

Impact of atherosclerosis imaging-quantitative computed tomography on diagnostic certainty, downstream testing, coronary revascularization, and medical therapy: the CERTAIN study

Authors

Nick S Nurmohamed,Jason H Cole,Matthew J Budoff,Ronald P Karlsberg,Himanshu Gupta,Lance E Sullenberger,Carlos G Quesada,Habib Rahban,Kevin M Woods,Jeffrey R Uzzilia,Scott L Purga,Melissa Aquino,Udo Hoffmann,James K Min,James P Earls,Andrew D Choi

Journal

European Heart Journal-Cardiovascular Imaging

Published Date

2024/1/25

Aims The incremental impact of atherosclerosis imaging-quantitative computed tomography (AI-QCT) on diagnostic certainty and downstream patient management is not yet known. The aim of this study was to compare the clinical utility of the routine implementation of AI-QCT versus conventional visual coronary CT angiography (CCTA) interpretation. Methods and results In this multi-centre cross-over study in 5 expert CCTA sites, 750 consecutive adult patients referred for CCTA were prospectively recruited. Blinded to the AI-QCT analysis, site physicians established patient diagnoses and plans for downstream non-invasive testing, coronary intervention, and medication management based on the conventional site assessment. Next, physicians were asked to repeat their assessments based upon AI-QCT results. The included patients had an age of 63.8 ± 12.2 years; 433 (57.7 …

Coronary Artery Calcium Scans Powered by Artificial Intelligence Predicts Atrial Fibrillation Comparably to Cardiac Magnetic Resonance Imaging: The Multi-Ethnic Study of …

Authors

Morteza Naghavi,Anthony P Reeves,Kyle C Atlas,Dong Li,Hamidreza Goodarzynejad,Chenyu Zhang,Thomas L Atlas,Claudia Henschke,Matthew J Budoff,David Yankelevitz

Journal

medRxiv

Published Date

2024

Background Applying artificial intelligence to coronary artery calcium computed tomography scan (AI-CAC) provides more actionable information beyond the Agatston coronary artery calcium (CAC) score. We have recently shown that AI-CAC automated left atrial (LA) volumetry enabled prediction of atrial fibrillation (AF) in as early as one year. In this study we evaluated the performance of AI-CAC automated LA volumetry versus LA volume measured by human experts using cardiac magnetic resonance imaging (CMRI) for predicting AF, and compared them with CHARGE-AF risk score, Agatston score, and NT-proBNP (BNP). Methods We used 15-year outcome data from 3137 asymptomatic individuals (52.2% women, age 61.7±10.2 years) who underwent both CAC scans and CMRI in the baseline examination (2000-2002) of the Multi-Ethnic Study of Atherosclerosis (MESA). AI-CAC took on average 21 seconds per scan. CMRI LA volume was previously measured by human experts. Data on BNP, CHARGE-AF risk score and the Agatston score were obtained from MESA. Results Over 15 years follow-up, 562 cases of AF accrued. The ROC AUC for AI-CAC versus CMRI and CHARGE-AF were not significantly different (AUC 0.807, 0.808, 0.800 respectively, p=0.60). The AUC for BNP (0.707) and Agatston score (0.694) were significantly lower than the rest (p<.0001). AI-CAC and CMRI significantly improved the continuous Net Reclassification Index (NRI) for prediction of AF when added to CHARGE-AF risk score (0.28, 0.31), BNP (0.43, 0.32), and Agatston score (0.69, 0.41) respectively (p for all<0.0001). Conclusion AI-CAC automated LA …

Can Noncalcified Plaques Contribute to Future Coronary Events?

Authors

Alastair J Moss,Michelle C Williams,David E Newby

Journal

JAMA cardiology

Published Date

2024/1/1

In Reply We thank Erbay and colleagues for their interest in our recent work regarding atherosclerotic plaque characterization using coronary 18F-sodium fluoride positron emission tomography. 1 They ask a timely question—does the monitoring of disease activity with target-specific radioligands provide additional clinical value beyond the quantitative anatomical assessment afforded by coronary computed tomography (CT) angiography?Historically, intravascular imaging of the coronary arteries with its attendant risks was the only method for evaluating coronary plaque composition. However, recent advances in imaging technology with photon-counting CT and totalbody positron emission tomography have given rise to the era of noninvasive molecular coronary imaging. Histological validation has demonstrated that 18F-sodium fluoride binds specifically to nanocrystalline hydroxyapatite, and somewhat …

Testosterone therapy and the risk of cardiovascular disease in older, hypogonadal men

Authors

Srikanth Krishnan,Jairo Aldana-Bitar,Ilana Golub,Keishi Ichikawa,Ayesha Shabir,Marziyeh Bagheri,Hossein Hamidi,Travis Benzing,Sina Kianoush,Matthew J Budoff

Published Date

2024/2/27

The debate over the cardiovascular (CV) implications of testosterone therapy (TT) have resulted in diverging safety recommendations and clinical guidelines worldwide. This narrative review synthesizes and critically evaluates long-term studies examining the effects of TT within the context of aging, obesity, and endogenous sex hormones on CV disease (CVD) risk to support informed clinical decision-making. Observational studies have variably linked low endogenous testosterone with increased CVD risk, while randomized controlled trials (RCTs) demonstrate that TT yields cardiometabolic benefits without increasing short-term CV risk. The TRAVERSE trial, as the first RCT powered to assess CVD events, did not show increased major adverse cardiac events (MACE) incidence; however, its limitations – specifically the maintenance of testosterone at low-normal levels, a high participant discontinuation rate, and …

Development and validation of a deep-learning model to predict 10-year atherosclerotic cardiovascular disease risk from retinal images using the UK Biobank and EyePACS 10K datasets

Authors

Hai Tang,Zhuochen Jin,Jiajun Deng,Yunlang She,Yifan Zhong,Weiyan Sun,Yijiu Ren,Nan Cao,Chang Chen

Journal

Journal of the American Medical Informatics Association

Published Date

2022/9/1

Background Patients in the intensive care unit (ICU) are often in critical condition and have a high mortality rate. Accurately predicting the survival probability of ICU patients is beneficial to timely care and prioritizing medical resources to improve the overall patient population survival. Models developed by deep learning (DL) algorithms show good performance on many models. However, few DL algorithms have been validated in the dimension of survival time or compared with traditional algorithms. Methods Variables from the Early Warning Score, Sequential Organ Failure Assessment Score, Simplified Acute Physiology Score II, Acute Physiology and Chronic Health Evaluation (APACHE) II, and APACHE IV models were selected for model development. The Cox regression, random survival forest (RSF), and DL methods were used to develop prediction models for the survival …

Coronary artery calcium for stroke mortality prediction

Authors

John Erhabor,Ellen Boakye,Zeina Dardari,Omar Dzaye,Garshasb Soroosh,Daniel S Berman,Matthew J Budoff,Michael D Miedema,Khurram Nasir,John A Rumberger,Leslee J Shaw,Michelle C Johansen,Michael J Blaha

Journal

Vascular Medicine

Published Date

2024/2/9

Coronary artery calcium for stroke mortality prediction - John Erhabor, Ellen Boakye, Zeina Dardari, Omar Dzaye, Garshasb Soroosh, Daniel S Berman, Matthew J Budoff, Michael D Miedema, Khurram Nasir, John A Rumberger, Leslee J Shaw, Michelle C Johansen, Michael J Blaha, 2024 Skip to main content Intended for healthcare professionals Sage Journals Home Search this journal Search all journals Enter search terms... SearchSearch Advanced search Enter search terms... SearchSearch Advanced search Search Access/ProfileAccess View access options View profile Create profile Cart Close Drawer MenuOpen Drawer MenuMenu Browse by discipline Select discipline: All disciplines All disciplines Health Sciences Life & Biomedical Sciences Materials Science & Engineering Social Sciences & Humanities Select subject: All subjects All subjects Allied Health Cardiology & Cardiovascular Medicine Dentistry …

Matrix Gla protein and the long-term incidence and progression of coronary artery and aortic calcification in the Multi-Ethnic Study of Atherosclerosis

Authors

Ashley A Berlot,Xueyan Fu,M Kyla Shea,Russell Tracy,Matthew Budoff,Ryung S Kim,Mahim Naveed,Sarah L Booth,Jorge R Kizer,Anna E Bortnick

Journal

Atherosclerosis

Published Date

2024/5/1

Background and aimsMatrix Gla protein (MGP) is an inhibitor of calcification that requires carboxylation by vitamin K for activity. The inactive form of MGP, dephosphorylated-uncarboxylated matrix Gla protein (dp-ucMGP), has been associated with increased calcification. However, it is not known whether there is a longitudinal relationship between dephosphorylated-uncarboxylated matrix Gla protein levels and coronary and aortic calcification in large population cohorts.MethodsThe Multi-Ethnic Study of Atherosclerosis (MESA) followed participants with serial cardiac computed tomography (CT) measures of vascular calcification. Dp-ucMGP was measured at baseline in a subset of participants who completed baseline and follow-up CTs approximately 10 years later and had available plasma specimens (n = 2663). Linear mixed effects models (LMMs) were used to determine the association of dp-ucMGP with the …

Methods and Reproducibility of Liver Fat Measurement Using 3-Dimensional Liver Segmentation From Noncontrast Computed Tomography in EVAPORATE Cohort

Authors

Kimberly R Ding,Suvasini Lakshmanan,Mateusz Holda,April Kinninger,Venkat S Manubolu,Tej Joshi,Ilana Golub,Song S Mao,Matthew J Budoff,Sion K Roy

Journal

Journal of Computer Assisted Tomography

Published Date

2024/1/1

ObjectiveNonalcoholic fatty liver disease not only shares multiple risk factors with cardiovascular disease but also independently predicts its increased risk and related outcomes. Here, we evaluate reproducibility of 3-dimensional (3D) liver volume segmentation method to identify fatty liver on noncontrast cardiac computed tomography (CT) and compare measures with previously validated 2-dimensional (2D) segmentation CT criteria for the measurement of liver fat.MethodsThe study included 68 participants enrolled in the EVAPORATE trial and underwent serial noncontrast cardiac CT. Liver attenuation< 40 Hounsfield units (HU) was used for diagnosing fatty liver, as done in the MESA study. Two-dimensional and 3D segmentation of the liver were performed by Philips software. Bland-Altman plot analysis was used to assess reproducibility.ResultsInterreader reproducibility of 3D liver mean HU measurements was …

AI-powered Coronary Artery Calcium Scans (AI-CAC) Enables Prediction of Heart Failure and Outperforms NT-proBNP: The Multi-Ethnic Study of Atherosclerosis

Authors

Morteza Naghavi,Anthony P Reeves,Matthew J Budoff,Dong Li,Kyle Atlas,Chenyu Zhang,Thomas Atlas,Claudia Henschke,Christopher Defilippi,Daniel Levy,David Yankelevitz

Journal

medRxiv

Published Date

2024

Introduction Coronary artery calcium (CAC) scans contain useful information beyond the Agatston CAC score that is not currently reported. We recently reported that artificial intelligence (AI)-enabled cardiac chambers volumetry in CAC scans (AI-CAC) predicted incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis (MESA). In this study, we investigated the performance of AI-CAC for prediction of incident heart failure (HF) and compared it with 10 known clinical risk factors, NT-proBNP, and the Agatston CAC score. Methods We applied AI-CAC to 5750 CAC scans of asymptomatic individuals (52% women, age 62±10 years, White 40%, Black 26%, Hispanic 22% Chinese 12%) free of known cardiovascular disease at the MESA baseline examination (2000-2002). We then used the 15-year outcomes data and compared the C-statistic of AI-CAC with NT-proBNP and the Agatston score for predicting incident HF versus 10 known clinical risk factors (age, gender, body surface area, diabetes, pre-baseline atrial fibrillation, current smoking, hypertension medication, systolic and diastolic blood pressure, LDL, HDL, total cholesterol, and hs-CRP). Results Over 15 years of follow-up, 256 HF events accrued. The ROC area under the curve for predicting HF with AI-CAC (0.826) was significantly higher than NT-proBNP (0.742) and Agatston score (0.712) (p<.0001), and comparable to clinical risk factors (0.818, p=0.4141). AI-CAC category-free NRI significantly improved on clinical risk factors (0.43), NT-proBNP (0.68), and Agatston score (0.71) for HF prediction at 15 years (p<0.0001). Conclusion AI-CAC significantly outperformed NT-proBNP …

Left Main Coronary Artery Calcium and Diabetes Confer Very-High-Risk Equivalence in Coronary Artery Calcium> 1,000

Authors

Alexander C Razavi,Leslee J Shaw,Daniel S Berman,Matthew J Budoff,Nathan D Wong,Viola Vaccarino,Marly van Assen,Carlo N De Cecco,Arshed A Quyyumi,Anurag Mehta,Paul Muntner,Michael D Miedema,Alan Rozanski,John A Rumberger,Khurram Nasir,Roger S Blumenthal,Laurence S Sperling,Martin Bødtker Mortensen,Seamus P Whelton,Michael J Blaha,Omar Dzaye

Journal

JACC: Cardiovascular Imaging

Published Date

2024/2/21

BackgroundAlthough a coronary artery calcium (CAC) of ≥1,000 is a subclinical atherosclerosis threshold to consider combination lipid-lowering therapy, differentiating very high from high atherosclerotic cardiovascular disease (ASCVD) risk in this patient population is not well-defined.ObjectivesAmong persons with a CAC of ≥1,000, the authors sought to identify risk factors equating with very high-risk ASCVD mortality rates.MethodsThe authors studied 2,246 asymptomatic patients with a CAC of ≥1,000 from the CAC Consortium without a prior ASCVD event. Cox proportional hazards regression modelling was performed for ASCVD mortality during a median follow-up of 11.3 years. Crude ASCVD mortality rates were compared with those reported for secondary prevention trial patients classified as very high risk, defined by ≥2 major ASCVD events or 1 major event and ≥2 high-risk conditions (1.4 per 100 …

Combination of computed tomography angiography with coronary artery calcium score for improved diagnosis of coronary artery disease: a collaborative meta-analysis of stable …

Authors

Mahmoud Mohamed,Maria Bosserdt,Viktoria Wieske,Benjamin Dubourg,Hatem Alkadhi,Mario J Garcia,Sebastian Leschka,Elke Zimmermann,Abbas A Shabestari,Bjarne L Nørgaard,Matthijs FL Meijs,Kristian A Øvrehus,Axel CP Diederichsen,Juhani Knuuti,Bjørn A Halvorsen,Vladymir Mendoza-Rodriguez,Yung-Liang Wan,Nuno Bettencourt,Eugenio Martuscelli,Ronny R Buechel,Hans Mickley,Kai Sun,Simone Muraglia,Philipp A Kaufmann,Bernhard A Herzog,Jean-Claude Tardif,Georg M Schütz,Michael Laule,David E Newby,Stephan Achenbach,Matthew Budoff,Robert Haase,Federico Biavati,Aldo Vásquez Mézquita,Peter Schlattmann,Marc Dewey,COME-CCT

Journal

European Radiology

Published Date

2024/4

ObjectivesCoronary computed tomography angiography (CCTA) has higher diagnostic accuracy than coronary artery calcium (CAC) score for detecting obstructive coronary artery disease (CAD) in patients with stable chest pain, while the added diagnostic value of combining CCTA with CAC is unknown. We investigated whether combining coronary CCTA with CAC score can improve the diagnosis of obstructive CAD compared with CCTA alone.MethodsA total of 2315 patients (858 women, 37%) aged 61.1 ± 10.2 from 29 original studies were included to build two CAD prediction models based on either CCTA alone or CCTA combined with the CAC score. CAD was defined as at least 50% coronary diameter stenosis on invasive coronary angiography. Models were built by using generalized linear mixed-effects models with a random intercept set for the original study. The two CAD prediction models were …

RACIAL AND ETHNIC DIFFERENCES IN LONG-TERM CARDIOVASCULAR MORTALITY AMONG WOMEN AND MEN FROM THE CAC CONSORTIUM

Authors

Samuel Aryeh Rosenblatt,Michael J Blaha,Ron Blankstein,Yvette Yeboah-Kordieh,Khurram Nasir,Fay Y Lin,Daniel S Berman,Michael D Miedema,Seamus P Whelton,John A Rumberger,Mathew Buddoff,Matthew J Budoff,Jonathon Leipsic,Leslee J Shaw

Journal

medRxiv

Published Date

2024

Background Despite an increasingly diverse population, knowledge regarding racial and ethnic disparities is limited among women and men undergoing atherosclerotic cardiovascular (ASCVD) screening. Our aim was to compare CV mortality by ASCVD risk and coronary artery calcium (CAC) scores among Black and Hispanic women and men compared to other participants. Design and Methods From the CAC Consortium, 42,964 participants with self-reported race and ethnicity were followed for a median of 11.7 years. Multivariable Cox proportional hazards regression models were used to estimate CV mortality, with separate analyses by sex. Results One-third of enrollees were women; 977 self-reported as Black, 1,349 as Hispanic, 1,621 as Asian, and 740 as American Indian/Native Alaskan/Hawaiian or other; the remainder were white. Black women and men had higher ASCVD risk and CAC scores yielding the highest CV mortality compared to other participants. Among Black women and men with a 0 CAC or ASCVD risk score <5%, hazard ratios (HRs) were 6-9-fold higher than that of other women and men. In men with CAC scores ≥100, Black men (HR: 4.2,p<0.001) had the highest CV mortality compared to all other men. A similar high-risk pattern was noted for Black women with CAC scores ≥100 (p<0.001), even when adjusting for the ASCVD risk score. Overall, Hispanics had an elevated CV mortality, higher than others but less than that of Black participants. Patterns of intermediate risk were notable for Hispanic men with a CAC score of 0 (HR=3.6, p=0.006) and ≥100 (HR=2.3, p=0.03). Conclusions The disproportionately high …

Factors Associated With Myocardial Infarction in a Rural Population With Peripheral Arterial Diseases

Authors

Adeola O Awujoola,Moboni T Mokikan,Olufeyisayo O Odebunmi,Hadii M Mamudu,David W Stewart,Ghaith Husari,Krishna Singh,Cori Grant,Matthew Budoff,Timir K Paul

Journal

Angiology

Published Date

2024/2/6

Peripheral arterial disease (PAD) studies in rural populations are limited. The incidence of myocardial infarction (MI) is higher in patients with PAD. This study examined the association between sociodemographic and clinical risk factors and MI in patients with PAD in Central Appalachia, comprising of 230 counties across six states in the United States. Data from electronic medical records of 13,455 patients with PAD were extracted from a large health system in Central Appalachia. Bivariate and logistic regression analyses were conducted. The final sample consisted of 5574 patients with PAD, of whom 24.85% were also diagnosed with MI. The mean age was 71 ± 11.23 years, and the majority were male (56.40%). After adjusting for confounders, patients with hypertension had three times higher odds of MI (adjusted Odds Ratio [aOR] = 3.21; 95% CI: 2.50–4.14) compared with those without hypertension. The …

Prevalence of aortic valve calcium and the long-term risk of incident severe aortic stenosis

Authors

Seamus P Whelton,Kunal Jha,Zeina Dardari,Alexander C Razavi,Ellen Boakye,Omar Dzaye,Dhiran Verghese,Sanjiv Shah,Matthew J Budoff,Kunihiro Matsushita,J Jeffery Carr,Ramachandran S Vasan,Roger S Blumenthal,Khalil Anchouche,George Thanassoulis,Xiuqing Guo,Jerome I Rotter,Robyn L McClelland,Wendy S Post,Michael J Blaha

Journal

JACC: Cardiovascular Imaging

Published Date

2023/5/10

Background Aortic valve calcification (AVC) is a principal mechanism underlying aortic stenosis (AS). Objectives This study sought to determine the prevalence of AVC and its association with the long-term risk for severe AS. Methods Noncontrast cardiac computed tomography was performed among 6,814 participants free of known cardiovascular disease at MESA (Multi-Ethnic Study of Atherosclerosis) visit 1. AVC was quantified using the Agatston method, and normative age-, sex-, and race/ethnicity-specific AVC percentiles were derived. The adjudication of severe AS was performed via chart review of all hospital visits and supplemented with visit 6 echocardiographic data. The association between AVC and long-term incident severe AS was evaluated using multivariable Cox HRs. Results AVC was present in 913 participants (13.4%). The probability of AVC >0 and AVC scores increased with age and were …

Association between long-term exposure to ambient air pollution and lesion ischemia in patients with atherosclerosis

Authors

Shew Fung Wong,Poh Sin Yap,Joon Wah Mak,Wan Ling Elaine Chan,Geok Lin Khor,Stephen Ambu,Wan Loy Chu,Maria Safura Mohamad,Norazizah Ibrahim Wong,Nur Liana Ab. Majid,Hamizatul Akmal Abd. Hamid,Wan Shakira Rodzlan Hasani,Muhammad Fadhli bin Mohd Yussoff,Hj Tahir bin Aris,Ezahtulsyahreen Bt Ab. Rahman,Zaleha Bt M. Rashid

Journal

Environmental Health

Published Date

2020/12

Background Malaysia has the highest rate of diabetes mellitus (DM) in the Southeast Asian region, and has ongoing air pollution and periodic haze exposure. Methods Diabetes data were derived from the Malaysian National Health and Morbidity Surveys conducted in 2006, 2011 and 2015. The air pollution data (NOx, NO2, SO2, O3 and PM10) were obtained from the Department of Environment Malaysia. Using multiple logistic and linear regression models, the association between long-term exposure to these pollutants and prevalence of diabetes among Malaysian adults was evaluated. Results The PM10 concentration decreased from 2006 to 2014, followed by an increase in 2015. Levels of NOx decreased while O3 increased annually. The air pollutant levels based on individual modelled air pollution exposure as …

Validation of Opportunistic Artificial Intelligence-Based Bone Mineral Density Measurements in Coronary Artery Calcium Scans

Authors

Morteza Naghavi,Kyle Atlas,Amirhossein Jaberzadeh,Chenyu Zhang,Venkat Manubolu,Dong Li,Matthew Budoff

Journal

Journal of the American College of Radiology

Published Date

2024/4/1

BackgroundPreviously we reported a manual method of measuring thoracic vertebral bone mineral density (BMD) using quantitative CT in noncontrast cardiac CT scans used for coronary artery calcium (CAC) scoring. In this report, we present validation studies of an artificial intelligence–based automated BMD measurement (AutoBMD) that recently received FDA approval as an opportunistic add-on to CAC scans.MethodsA deep learning model was trained to detect vertebral bodies. Subsequently, signal processing techniques were developed to detect intervertebral discs and the trabecular components of the vertebral body. The model was trained using 132 CAC scans comprising 7,649 slices. To validate AutoBMD, we used 5,785 cases of manual BMD measurements previously reported from CAC scans in the Multi-Ethnic Study of Atherosclerosis.ResultsMean ± SD for AutoBMD and manual BMD were 166.1 ± …

AI-enabled Left Atrial Volumetry in Cardiac CT Scans Improves CHARGE-AF and Outperforms NT-ProBNP for Prediction of Atrial Fibrillation in Asymptomatic Individuals: Multi …

Authors

Morteza Naghavi,David Yankelevitz,Anthony P Reeves,Matthew J Budoff,Dong Li,Kyle Atlas,Chenyu Zhang,Thomas Atlas,Daniel Levy,Jakob Wasserthal,Seth Lirette,Claudia Henschke,Christopher Defilippi,Susan Heckbert,Philip Greenland

Journal

medRxiv

Published Date

2024

Background Coronary artery calcium (CAC) scans contain actionable information beyond CAC scores that is not currently reported. Methods We have applied artificial intelligence-enabled automated cardiac chambers volumetry to CAC scans (AI-CAC) of 5535 asymptomatic individuals (52.2% women, ages 45-84) that were previously obtained for CAC scoring in the baseline examination (2000-2002) of the Multi-Ethnic Study of Atherosclerosis (MESA). We then used the 5-year outcomes data and compared the C-statistic of the AI-CAC LA volume with known predictors of atrial fibrillation (AF), the CHARGE-AF Risk Score and NT-proBNP (BNP) for prediction of incident AF. The AI-CAC automated cardiac chambers volumetry took on average 21 seconds per CAC scan. Results At 1,2,3,4, and 5 years follow up 36, 77, 123, 182, and 236 cases of AF were identified respectively. The C-statistic AUC for AI-CAC LA volume was significantly higher than CHARGE-AF or BNP at year 1 (0.836, 0.742, 0.742), year 2 (0.842, 0.807,0.772), and year 3 (0.811, 0.785, 0.745) (p<0.02). For year 4 (0.785, 0.769, 0.725) and year 5 (0.781, 0.767, 0.734) respectively (p>0.05). AI-CAC LA volume significantly improved the continuous Net Reclassification Index for prediction of AF at year 1-5 when added to CAC score (0.74, 0.49, 0.53, 0.39, 0.44), CHARGE-AF Risk Score (0.60, 0.28, 0.32, 0.19, 0.24), and BNP (0.68, 0.44, 0.42, 0.30, 0.37) respectively (p<0.01). Conclusion AI-CAC LA volume enabled prediction of AF as early as one year and significantly improved on risk classification of CHARGE-AF Risk Score and BNP.

The Relationship of Matrix Gla Protein With Coronary and Extracoronary Calcification in the Multi-Ethnic Study of Atherosclerosis

Authors

Ashley A Berlot,Xueyan Fu,Kyla Shea,Russell Tracy,Matthew J Budoff,Ryung Kim,Mahim Naveed,Sarah Booth,Jorge R Kizer,Anna E Bortnick

Journal

Circulation

Published Date

2023/11/7

Introduction: Vascular calcification regulators are understudied. Matrix Gla protein (MGP) is a calcification inhibitor, and its inactive dephosphorylated-uncarboxylated (dp-ucMGP) form has been linked to calcification. The longitudinal relationship of dp-ucMGP with coronary and extracoronary artery calcification in large populations is unknown. Hypothesis: Higher levels of dp-ucMGP may be associated with greater coronary artery, ascending thoracic aortic, and descending thoracic aortic calcification (CAC, ATAC, DTAC). Aim: To determine the association of dp-ucMGP with CAC, ATAC, and DTAC. Methods: Calcification was measured on serial thoracic computed tomography (CT) scans in the Multi-Ethnic Study of Atherosclerosis (MESA, n=6814). Dp-ucMGP was measured at baseline in a random subset of available serum samples (n=2663), 2539 included in the fully adjusted models) in participants with a baseline …

Evaluation of image quality for high heart rates for coronary computed tomographic angiography with advancement in CT technology: the CONVERGE registry

Authors

Ayman Abdelkarim,Sion K Roy,April Kinninger,Azadeh Salek,Olivia Baranski,Daniele Andreini,Gianluca Pontone,Edoardo Conte,Rachael O’Rourke,Christian Hamilton-Craig,Matthew J Budoff

Journal

Journal of Cardiovascular Development and Disease

Published Date

2023/9/19

Objective This study aims to evaluate image quality in patients with heart rates above or equal to 70 beats per minute (bpm), performed on a 16 cm scanner (256-slice General Electric Revolution) in comparison to a CT scanner with only 4 cm of coverage (64 slice Volume CT). Background Recent advancements in image acquisition, such as whole-heart coverage in a single rotation and post-processing methods in coronary computed tomographic angiography (CCTA), include motion-correction algorithms, such as SnapShot Freeze (SSF), which improve temporal resolution and allow for the assessment of coronary artery disease (CAD) with lower motion scores and better image qualities. Studies from the comprehensive evaluation of high temporal- and spatial-resolution cardiac CT using a wide coverage system (CONVERGE) registry (a multicenter registry at four centers) have shown the 16 cm CT scanner having a better image quality in comparison to the 4 cm scanner. However, these studies failed to include patients with undesirable or high heart rates due to well-documented poor image acquisition on prior generations of CCTA scanners. Methods A prospective, observational, multicenter cohort study comparing image quality, quantitively and qualitatively, on scans performed on a 16 cm CCTA in comparison to a cohort of images captured on a 4 cm CCTA at four centers. Participants were recruited based on broad inclusion criteria, and each patient in the 16 cm CCTA arm of the study received a CCTA scan using a 256-slice, whole-heart, single-beat scanner. These patients were then matched by age, gender, and heart rate to patients who …

Coronary Artery Calcium is Associated With Cardiovascular Disease and Poorer Survival in Patients Undergoing Autologous Hematopoietic Cell Transplantation

Authors

Stephanie Y Wu,June W Rhee,Aleksi Iukuridze,Alysia Bosworth,Sitong Chen,Liezl Atencio,Venkat Manubolu,Rusha Bhandari,Faizi Jamal,Matthew Mei,Alex Herrera,Stephen Forman,Ryotaro Nakamura,Lennie Wong,Matthew J Budoff,Saro Armenian

Journal

Circulation

Published Date

2023/11/7

Background: Hematopoietic cell transplantation (HCT) is an established curative treatment for patients with hematologic malignancies, however survivors are at a >4-fold risk of cardiovascular disease ([CVD] heart failure, myocardial infarction, stroke]) compared to the general population. Coronary artery calcium (CAC) is predictive of CVD in non-oncology patients; less is known about its association with CVD risk and outcomes after HCT. Methods: This was a retrospective cohort study of 243 consecutive patients who underwent first autologous HCT for Hodgkin/non-Hodgkin lymphoma between 2009-2014 with no history of CVD. CAC was determined from chest computed tomography performed <60d from HCT; measurements (Agatston unit) were made by trained researchers blinded to patient demographics and outcomes. CAC was categorized as: 0, 1-100, >100. Multivariable Cox regression analysis was used …

Genome-wide association meta-analysis identifies 17 loci associated with nonalcoholic fatty liver disease

Authors

Yanhua Chen,Xiaomeng Du,Annapurna Kuppa,Mary F Feitosa,Lawrence F Bielak,Jeffrey R O’Connell,Solomon K Musani,Xiuqing Guo,Bratati Kahali,Vincent L Chen,Albert V Smith,Kathleen A Ryan,Gudny Eirksdottir,Matthew A Allison,Donald W Bowden,Matthew J Budoff,John Jeffrey Carr,Yii-Der I Chen,Kent D Taylor,Antonino Oliveri,Adolfo Correa,Breland F Crudup,Sharon LR Kardia,Thomas H Mosley Jr,Jill M Norris,James G Terry,Jerome I Rotter,Lynne E Wagenknecht,Brian D Halligan,Kendra A Young,John E Hokanson,George R Washko,Vilmundur Gudnason,Michael A Province,Patricia A Peyser,Nicholette D Palmer,Elizabeth K Speliotes

Journal

Nature Genetics

Published Date

2023/10

Nonalcoholic fatty liver disease (NAFLD) is common and partially heritable and has no effective treatments. We carried out a genome-wide association study (GWAS) meta-analysis of imaging (n = 66,814) and diagnostic code (3,584 cases versus 621,081 controls) measured NAFLD across diverse ancestries. We identified NAFLD-associated variants at torsin family 1 member B (TOR1B), fat mass and obesity associated (FTO), cordon-bleu WH2 repeat protein like 1 (COBLL1)/growth factor receptor-bound protein 14 (GRB14), insulin receptor (INSR), sterol regulatory element-binding transcription factor 1 (SREBF1) and patatin-like phospholipase domain-containing protein 2 (PNPLA2), as well as validated NAFLD-associated variants at patatin-like phospholipase domain-containing protein 3 (PNPLA3), transmembrane 6 superfamily 2 (TM6SF2), apolipoprotein E (APOE), glucokinase regulator (GCKR), tribbles …

OR25-06 The Effect of Testosterone Replacement Therapy on NAFLD in Elderly Hypogonadal Men

Authors

Hae Seung Lee,Sang Hun Han,Ronald S Swerdloff,Youngju Pak,Matthew J Budoff,Christina CL Wang

Journal

Journal of the Endocrine Society

Published Date

2023/10

Disclosure: H. Lee: None. S. Han: None. R.S. Swerdloff: None. Y. Pak: None. M.J. Budoff: None. C.C. Wang: None. The Effect of Testosterone Replacement Therapy on NAFLD in Elderly Hypogonadal Men Background: Aging increases body weight, visceral fat, insulin resistance and metabolic syndrome, leading to increased prevalence of nonalcoholic fatty liver disease(NAFLD) in elderly. Testosterone deficiency, more prevalent in elderly men, is associated with metabolic syndrome and increased visceral fat. The T Trials evaluated the effect of testosterone treatment on sexual function, physical function, and vitality. A substudy on the effect of testosterone on cardiovascular markers showed decrease in total cholesterol, LDL cholesterol, HDL cholesterol, fasting insulin level and HOMA-IR in testosterone treatment group compared to placebo. We hypothesized that testosterone …

Better Prognostic Value of Single Time Coronary Artery Calcium Score Over the 30-y Averaged Pooled Cohort Equation in Older Adults: The Atherosclerosis Risk in Communities …

Authors

Yejin Mok,Yasuyuki Honda,Frances Wang,Candace M Howard,Aaron R Folsom,Josef Coresh,Matthew J Budoff,Michael J Blaha,Kuni Matsushita

Journal

Circulation

Published Date

2023/11/7

Background: Cardiovascular disease (CVD) risk prediction in the 75-and-older population is challenging in part because traditional risk factors at older age may not reflect the risk factor profile over the life course. In this regard, coronary artery calcium (CAC) can be considered an integrated biomarker of exposure to CVD risk factors. However, the predictive value of a single time point CAC at older age vs. the cumulative exposure of traditional risk factors over three decades is unknown. Methods: In 1,875 ARIC participants (age 75-94 years) without a history of coronary heart disease (CHD), stroke, and heart failure (HF) at Visit 7 (2018-2019), we assessed the association of Visit 7 CAC vs. a weighted average of Pooled Cohort Equation (PCE) calculated 10-year atherosclerotic CVD (ASCVD) risk from Visit 1 (1987-89) to Visit 7 with the risk of ASCVD (CHD or stroke), HF, and all-cause mortality using adjusted Cox …

Predictive Value of Deep Learning–derived CT Pectoralis Muscle and Adipose Measurements for Incident Heart Failure: Multi-Ethnic Study of Atherosclerosis

Authors

Quincy Hathaway,Hamza Ahmed Ibad,David A Bluemke,Farhad Pishgar,Arta Kasaiean,Joshua G Klein,Rebecca Cogswell,Matthew Allison,Matthew J Budoff,R Graham Barr,Wendy Post,Miriam A Bredella,João AC Lima,Shadpour Demehri

Journal

Radiology: Cardiothoracic Imaging

Published Date

2023/10/5

Purpose To develop a deep learning algorithm capable of extracting pectoralis muscle and adipose measurements and to longitudinally investigate associations between these measurements and incident heart failure (HF) in participants from the Multi-Ethnic Study of Atherosclerosis (MESA). Materials and Methods MESA is a prospective study of subclinical cardiovascular disease characteristics and risk factors for progression to clinically overt disease approved by institutional review boards of six participating centers (ClinicalTrials.gov identifier: NCT00005487). All participants with adequate imaging and clinical data from the fifth examination of MESA were included in this study. Hence …

Statins influence the relationship between ATP-binding cassette A1 membrane transporter-mediated cholesterol efflux capacity and coronary atherosclerosis in rheumatoid arthritis

Authors

George A Karpouzas,Bianca Papotti,Sarah R Ormseth,Marcella Palumbo,Elizabeth Hernandez,Maria Pia Adorni,Francesca Zimetti,Matthew J Budoff,Nicoletta Ronda

Journal

Journal of Translational Autoimmunity

Published Date

2023/12/1

ObjectivesCholesterol efflux capacity (CEC) is the main antiatherogenic function of high-density lipoprotein (HDL). ATP-binding-cassette A1 (ABCA1) membrane transporter initiates cholesterol export from arterial macrophages to pre-β HDL particles fostering their maturation; in turn, those accept cholesterol through ABCG1-mediated export. Impaired pre-β HDL maturation may disrupt the collaborative function of the two transporters and adversely affect atherosclerosis. Statins exert atheroprotective functions systemically and locally on plaque. We here evaluated associations between ABCA1-CEC, coronary atherosclerosis and cardiovascular risk and the influence of statins on those relationships in rheumatoid arthritis (RA).MethodsEvaluation with computed tomography angiography was undertaken in 140 patients and repeated in 99 after 6.9 ± 0.3 years. Events comprising cardiovascular death, acute coronary …

Plasma Interleukin-6 (IL-6), Angiopoietin-2, and C-Reactive Protein Levels Predict Subsequent Type 1 Myocardial Infarction in Persons with Treated HIV Infection

Authors

Susan M Graham,Robin M Nance,Junmei Chen,Mark M Wurfel,Peter W Hunt,Susan R Heckbert,Matthew J Budoff,Richard D Moore,Jeffrey M Jacobson,Jeffrey N Martin,Heidi M Crane,José A López,W Conrad Liles

Journal

JAIDS Journal of Acquired Immune Deficiency Syndromes

Published Date

2023/8/1

Background:HIV infection leads to endothelial activation, promoting platelet adhesion, and accelerating atherosclerosis. Our goal was to determine whether biomarkers of endothelial activation and hemostasis/thrombosis were elevated in people with treated HIV (PWH) before myocardial infarction (MI).Methods:In a case–control study nested within the CFAR Network of Integrated Clinical Systems (CNICS) cohort, we compared 69 adjudicated cases with type 1 MI with 138 controls matched for antiretroviral therapy regimen. We measured angiopoietin-1, angiopoietin-2 (ANG-2), intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13), von Willebrand factor, C-reactive protein (CRP), interleukin-6 (IL-6), plasminogen activation inhibitor-1, P-selectin, serum amyloid-A, soluble CD14, and …

How early can atherosclerosis be detected by coronary CT angiography? Insights from quantitative CT analysis of serial scans in the PARADIGM trial

Authors

Rhanderson Cardoso,Andrew D Choi,Arthur Shiyovich,Stephanie A Besser,James K Min,James Earls,Daniele Andreini,Mouaz H Al-Mallah,Matthew J Budoff,Filippo Cademartiri,Kavitha Chinnaiyan,Jung Hyun Choi,Eun Ju Chun,Edoardo Conte,Ilan Gottlieb,Martin Hadamitzky,Yong-Jin Kim,Byoung Kwon Lee,Jonathon A Leipsic,Erica Maffei,Hugo Marques,Pedro de Araújo Gonçalves,Gianluca Pontone,Sang-Eun Lee,Ji Min Sung,Renu Virmani,Habib Samady,Fay Y Lin,Peter H Stone,Daniel S Berman,Jagat Narula,Leslee J Shaw,Jeroen J Bax,Hyuk-Jae Chang,Ron Blankstein

Journal

Journal of cardiovascular computed tomography

Published Date

2023/11/1

BackgroundNon-obstructing small coronary plaques may not be well recognized by expert readers during coronary computed tomography angiography (CCTA) evaluation. Recent developments in atherosclerosis imaging quantitative computed tomography (AI-QCT) enabled by machine learning allow for whole-heart coronary phenotyping of atherosclerosis, but its diagnostic role for detection of small plaques on CCTA is unknown.MethodsWe performed AI-QCT in patients who underwent serial CCTA in the multinational PARADIGM study. AI-QCT results were verified by a level III experienced reader, who was blinded to baseline and follow-up status of CCTA. This retrospective analysis aimed to characterize small plaques on baseline CCTA and evaluate their serial changes on follow-up imaging. Small plaques were defined as a total plaque volume <50 ​mm3.ResultsA total of 99 patients with 502 small plaques …

Sex and age-specific interactions of coronary atherosclerotic plaque onset and prognosis from coronary computed tomography

Authors

Sophie E van Rosendael,A Maxim Bax,Fay Y Lin,Stephan Achenbach,Mouaz H Al-Mallah,Daniele Andreini,Matthew J Budoff,Filippo Cademartiri,Tracy Q Callister,Kavitha Chinnaiyan,Benjamin JW Chow,Ricardo C Cury,Augustin J DeLago,Gudrun Feuchtner,Martin Hadamitzky,Joerg Hausleiter,Philipp A Kaufmann,Yong-Jin Kim,Jonathon A Leipsic,Erica Maffei,Hugo Marques,Pedro de Araújo Gonçalves,Gianluca Pontone,Gilbert L Raff,Ronen Rubinshtein,Todd C Villines,Hyuk-Jae Chang,Daniel S Berman,James K Min,Jeroen J Bax,Leslee J Shaw,Alexander R van Rosendael

Journal

European Heart Journal-Cardiovascular Imaging

Published Date

2023/9

Aims The totality of atherosclerotic plaque derived from coronary computed tomography angiography (CCTA) emerges as a comprehensive measure to assess the intensity of medical treatment that patients need. This study examines the differences in age onset and prognostic significance of atherosclerotic plaque burden between sexes. Methods and results From a large multi-center CCTA registry the Leiden CCTA score was calculated in 24 950 individuals. A total of 11 678 women (58.5 ± 12.4 years) and 13 272 men (55.6 ± 12.5 years) were followed for 3.7 years for major adverse cardiovascular events (MACE) (death or myocardial infarction). The age where the median risk score was above zero was 12 years higher in women vs. men (64–68 years vs. 52–56 years, respectively, P < 0.001). The Leiden CCTA risk score was independently associated with MACE: score 6–20 …

Association of Gender-Affirming Hormone Treatment With Metabolic Syndrome in Transgender Patients Compared With Cis-Gender Patients

Authors

Andriana Marijic Buljubasic,Michael Goodman,Matthew J Budoff,Jeffrey Gornbein,Leila Hashemi

Journal

Circulation

Published Date

2023/11/7

Background: The long-term effects of gender-affirming hormone therapy (GAHT) is an area of priority in transgender (TG) health research. Also, there is a great gap in our understanding of sex hormone and sex chromosomes and their role in Metabolic Syndrome (MetS) and therefore atherosclerosis risk. Hypothesis: sex hormones, (estradiol and Testosterone) affect the development of MetS and therefore heart disease. Methods: Using International Classification of Diseases ninth and tenth codes for gender dysphoria from the Veteran Health Affairs national data, we identified 284 transfeminine (TF) and 79 transmasculine (TM) patients with documented received GAHT initiation date (index date=ID) and MetS components data. GAHT consists of estradiol in TF and testosterone in TM individuals.TG individuals were matched to 252 cis-male (CM) and 111 cis-female (CF) referents. MetS z-scores were calculated as …

Cardiovascular risk stratification among individuals with obesity: The Coronary Artery Calcium Consortium

Authors

Ellen Boakye,Gowtham R Grandhi,Zeina Dardari,Rishav Adhikari,Garshasb Soroosh,Kunal Jha,Omar Dzaye,Erfan Tasdighi,John Erhabor,Sant J Kumar,Seamus Whelton,Roger S Blumenthal,Michael Albert,Alan Rozanski,Daniel S Berman,Matthew J Budoff,Michael D Miedema,Khurram Nasir,John A Rumberger,Leslee J Shaw,Michael Blaha

Journal

Obesity

Published Date

2023/8/3

Objective The effectiveness of coronary artery calcification (CAC) for risk stratification in obesity, in which imaging is often limited because of a reduced signal to noise ratio, has not been well studied. Methods Data from 9334 participants (mean age: 53.3 ± 9.7 years; 67.9% men) with BMI ≥ 30 kg/m2 from the CAC Consortium, a retrospectively assembled cohort of individuals with no prior cardiovascular diseases (CVD), were used. The predictive value of CAC for all‐cause and cause‐specific mortality was evaluated using multivariable‐adjusted Cox proportional hazards and competing‐risks regression. Results Mean BMI was 34.5 (SD 4.4) kg/m2 (22.7% Class II and 10.8% Class III obesity), and 5461 (58.5%) had CAC. Compared with CAC = 0, those with CAC = 1–99, 100–299, and ≥300 Agatston units had higher rates (per 1000 person‐years) of all‐cause (1.97 vs. 3.5 vs. 5.2 vs. 11.3), CVD (0.4 …

Deep-Learning-Based Assessment of Left Atrial Volume in Coronary Calcium CT: Association With NT-proBNP and Clinical Outcomes

Authors

Fernando Kay,Shawn Simek,Suhny Abbara,Colby Ayers,Sonia Garg,Ambarish Pandey,Amit Khera,Mark H Drazner,Anand Rohatgi,Matthew J Budoff,James A de Lemos,Ronald M Peshock,Parag H Joshi

Journal

Circulation

Published Date

2023/11/7

Introduction: Artificial Intelligence (AI) promises to extract imaging biomarkers for cardio-cerebrovascular (CV) risk prediction, though validation is still lacking. Recognizing the importance of left atrial pathology on CV events, we developed an AI algorithm to measure left atrial volume (LAvol) from CAC-CT. Its correlation with MRI, biomarkers, and CV incidents was then tested in the Dallas Heart Study 2 (DHS). Hypothesis: LAvol will be associated with elevations in baseline NT-proBNP levels and incident CV events. Methods: We trained a 3D U-Net model for cardiac chamber segmentation on CAC-CT, assessing congruity with manual segmentation via the Dice score. Normalized left atrial volume (LAvol/BSA) from 3D segmentations was compared to MRI using ICC, and its associations with baseline NT-proBNP and incident Afib, TIA, and stroke were evaluated with logistic regression and Cox models. Results …

Impact of complete revascularization in the ISCHEMIA trial

Authors

Gregg W Stone,Ziad A Ali,Sean M O’Brien,Grace Rhodes,Philippe Genereux,Sripal Bangalore,Kreton Mavromatis,Jennifer Horst,Ovidiu Dressler,Kian Keong Poh,Ranjit K Nath,Nagaraja Moorthy,Adam Witkowski,Sudhanshu K Dwivedi,Olga Bockeria,Jiyan Chen,Paola EP Smanio,Michael H Picard,Bernard R Chaitman,Daniel S Berman,Leslee J Shaw,William E Boden,Harvey D White,Stephen E Fremes,Yves Rosenberg,Harmony R Reynolds,John A Spertus,Judith S Hochman,David J Maron

Journal

Journal of the American College of Cardiology

Published Date

2023/9/19

Background Anatomic complete revascularization (ACR) and functional complete revascularization (FCR) have been associated with reduced death and myocardial infarction (MI) in some prior studies. The impact of complete revascularization (CR) in patients undergoing an invasive (INV) compared with a conservative (CON) management strategy has not been reported. Objectives Among patients with chronic coronary disease without prior coronary artery bypass grafting randomized to INV vs CON management in the ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial, we examined the following: 1) the outcomes of ACR and FCR compared with incomplete revascularization; and 2) the potential impact of achieving CR in all INV patients compared with CON management. Methods ACR and FCR in the INV group were assessed at an independent …

The Influence of Abdominal Obesity on the Accuracy of Cardiovascular Risk Prediction in Rheumatoid Arthritis

Authors

George A Karpouzas,Elizabeth Hernandez,Matthew J Budoff,Sarah R Ormseth

Journal

Medical Research Archives

Published Date

2023/9/28

Objectives. Underweight patients with rheumatoid arthritis incur greater total and cardiovascular mortality compared to overweight or obese. We explored whether obesity confounded cardiovascular risk estimates and the potential utility of noninvasive coronary atherosclerosis assessment and cardiac damage biomarkers in optimizing risk prediction in obese patients with rheumatoid arthritis.Methods. We evaluated 150 participants undergoing screening atherosclerosis evaluation with coronary computed tomography angiography and follow-up over 6.0±2.4 years. Framingham 2008 modified general cardiovascular risk score was computed at baseline. Obesity was defined as waist circumference> 88 cm in females and> 102 cm in males. Serum highly-sensitive cardiac troponin I (hs-cTnI) and leptin were measured at baseline.Results. An interaction between the Framingham risk score and obesity on cardiovascular risk was observed (p= 0.032); lower estimates were seen in obese (area under the curve-AUC 0.660, 95% CI 0.487-0.832) vs. non-obese patients (AUC 0.952, 95% CI 0.897-1.007, p= 0.002). Likewise, risk estimates were inferior in patients with high (> 22.1 ng/ml) vs. low leptin (AUC 0.618, 95% CI 0.393-0.842 vs. 0.874, 95% CI 0.772-0.976, p= 0.042). In obese patients, sequential addition of the top highly-sensitive cardiac troponin I tertile values and extensive atherosclerotic plaque (> 5 segments) information to a base model including the Framingham risk score alone significantly improved risk estimates, based on changes in net reclassification index (1.093 95% CI 0.517-1.574), integrated discrimination improvement (0.188, 95 …

Reply: The Blurry Line Between Primary and Secondary Prevention: Should We Continue to Use These Terms?

Authors

Matthew J Budoff,April Kinninger

Journal

Cardiovascular Imaging

Published Date

2023/10/1

We read with interest the letter by Dr Núñez regarding our paper. 1 However, until the terms are no longer used (in guidelines, by physicians, as consideration by pharmacy benefits managers), it is important clinically to show when and if independent risk markers (such as coronary artery calcium [CAC] or chronic kidney disease) achieve similar risk to those who survived a cardiovascular event. The study in question, showing persons with CAC have markedly elevated risk even before their event, substantiates his point. 1Unfortunately, guidelines and indications for certain therapies are solely based on those who have established atherosclerotic cardiovascular disease (ASCVD). Those persons who have extensive atherosclerosis (ie, CAC> 300) are at similar risk to a survivor of myocardial infarction, but cannot claim the mantle “established coronary artery disease” yet. We must strive toward the goals set forth by Dr …

Association of diabetes with coronary artery calcium in South Asian adults and other race/ethnic groups: The multi-ethnic study of atherosclerosis and the mediators of …

Authors

Ned Premyodhin,Wenjun Fan,Millie Arora,Matthew J Budoff,Alka M Kanaya,Namratha Kandula,Latha Palaniappan,Jamal S Rana,Masood Younus,Nathan D Wong

Journal

Diabetes & Vascular Disease Research

Published Date

2023/10/5

PurposeSouth Asian (SA) persons have increased risks for diabetes mellitus (DM) and atherosclerotic cardiovascular disease (ASCVD). We examined whether the association of DM with subclinical atherosclerosis assessed by coronary artery calcium (CAC) differs in SA versus other ethnic groups.MethodsWe studied adults from the Multi-Ethnic Study of Atherosclerosis and the Mediators of Atherosclerosis in South Asians Living in America studies without ASCVD. CAC was examined among those normoglycemic, pre-DM and DM. Logistic regression examined pre-DM and DM with the odds of any CAC > 0 and CAC ≥ 100.ResultsAmong 7562 participants, CAC > 0 and CAC ≥ 100 in those with DM was highest in non-Hispanic White (NHW) (80% and 48%) and SA (72% and 41%) persons. Adjusted Ln (CAC + 1) was highest in NHW (3.68 ± 0.21) and SA (3.60 ± 0.23) (p < .01) DM patients. SA and NHW adults …

Thoracic Aortic Calcium Density and Area in Long-Term Atherosclerotic Cardiovascular Disease Risk Among Men Versus Women

Authors

Alexander C Razavi,Cherry Kim,Marly Van Assen,Carlo N De Cecco,Daniel S Berman,Matthew J Budoff,Arshed A Quyyumi,Viola Vaccarino,Michael D Miedema,Khurram Nasir,Alan Rozanski,Camilo Fernandez,John A Rumberger,Leslee J Shaw,Martin Bødtker Mortensen,Nathan D Wong,Roger S Blumenthal,Laurence S Sperling,Seamus P Whelton,Michael J Blaha,Omar Dzaye

Journal

Circulation: Cardiovascular Imaging

Published Date

2023/12

BACKGROUND The development of thoracic aortic calcium (TAC) temporally precedes coronary artery calcium more often in women versus men. Whether TAC density and area confer sex-specific differences in atherosclerotic cardiovascular disease (ASCVD) risk is unknown. METHODS We studied 5317 primary prevention patients who underwent coronary artery calcium scoring on noncontrast cardiac gated computed tomography with TAC >0. The Agatston TAC score (Agatston units), density (Hounsfield units), and area (mm2) were compared between men and women. Cox proportional hazards regression calculated adjusted hazard ratios for TAC density-area groups with ASCVD mortality, adjusting for traditional risk factors, coronary artery calcium, and TAC. Multinomial logistic regression calculated adjusted odds ratios for the association between traditional risk factors and TAC density-area groups …

Vendor Independent Coronary Calcium Scoring Improves Individual Risk Assessment: MESA (Multi-Ethnic Study of Atherosclerosis)

Authors

Niels R van der Werf,Magdalena M Dobrolinska,Marcel JW Greuter,Martin J Willemink,Dominik Fleischmann,Daniel Bos,Riemer HJA Slart,Matthew Budoff,Tim Leiner

Journal

Cardiovascular Imaging

Published Date

2023/12/1

Background Substantial variation in Agatston scores (AS) acquired with different computed tomography (CT) scanners may influence patient risk classification. Objectives This study sought to develop a calibration tool for state-of-the-art CT systems resulting in vendor-neutral AS (vnAS), and to assess the impact of vnAS on coronary heart disease (CHD) event prediction. Methods The vnAS calibration tool was derived by imaging 2 anthropomorphic calcium containing phantoms on 7 different CT and 1 electron beam tomography system, which was used as the reference system. The effect of vnAS on CHD event prediction was analyzed with data from 3,181 participants from MESA (Multi-Ethnic Study on Atherosclerosis). Chi-square analysis was used to compare CHD event rates between low (vnAS <100) and high calcium groups (vnAS ≥100). Multivariable Cox proportional hazard regression models were used …

Evaluation of stable angina by coronary computed tomographic angiography versus standard of care: A systematic review and meta-analysis

Authors

Anirudh Palicherla,Mahmoud Ismayl,Abhishek Thandra,Matthew Budoff,Kashif Shaikh

Published Date

2023/7/27

IntroductionThere is limited data comparing Coronary Computed Tomography Angiography (CCTA) versus the usual Standard of care (SOC) in patients with suspected stable coronary artery disease (CAD). We aimed to perform a systematic review and meta-analysis to compare CCTA versus SOC in patients with stable CAD.MethodsWe searched multiple databases for randomized controlled trials (RCTs) comparing CCTA with SOC, which included various functional testing approaches for evaluating stable CAD. We used a random-effects model to calculate risk ratios (RRs) with 95 % confidence intervals (CIs). Outcomes included all-cause mortality, myocardial infarction (MI), hospitalization for unstable angina (UA), invasive angiography, revascularization, percutaneous coronary intervention (PCI), and coronary artery bypass grafting (CABG).ResultsWe identified 6 RCTs with 19,881 patients with stable CAD, of …

Impact of statins based on high-risk plaque features on coronary plaque progression in mild stenosis lesions: results from the PARADIGM study

Authors

Hyung-Bok Park,Reza Arsanjani,Ji Min Sung,Ran Heo,Byoung Kwon Lee,Fay Y Lin,Martin Hadamitzky,Yong-Jin Kim,Edoardo Conte,Daniele Andreini,Gianluca Pontone,Matthew J Budoff,Ilan Gottlieb,Eun Ju Chun,Filippo Cademartiri,Erica Maffei,Hugo Marques,Pedro de Araújo Gonçalves,Jonathon A Leipsic,Sang-Eun Lee,Sanghoon Shin,Jung Hyun Choi,Renu Virmani,Habib Samady,Kavitha Chinnaiyan,Peter H Stone,Daniel S Berman,Jagat Narula,Leslee J Shaw,Jeroen J Bax,James K Min,Hyuk-Jae Chang

Journal

European Heart Journal-Cardiovascular Imaging

Published Date

2023/11

Aims To investigate the impact of statins on plaque progression according to high-risk coronary atherosclerotic plaque (HRP) features and to identify predictive factors for rapid plaque progression in mild coronary artery disease (CAD) using serial coronary computed tomography angiography (CCTA). Methods and results We analyzed mild stenosis (25–49%) CAD, totaling 1432 lesions from 613 patients (mean age, 62.2 years, 63.9% male) and who underwent serial CCTA at a ≥2 year inter-scan interval using the Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging (NCT02803411) registry. The median inter-scan period was 3.5 ± 1.4 years; plaques were quantitatively assessed for annualized percent atheroma volume (PAV) and compositional plaque volume changes according to HRP features, and the rapid plaque …

Artificial intelligence using a deep learning versus expert computed tomography human reading in calcium score and coronary artery calcium data and reporting system classification

Authors

Jairo Aldana-Bitar,Geoffrey W Cho,Lauren Anderson,Daniel W Karlsberg,Venkat S Manubolu,Dhiran Verghese,Luay Hussein,Matthew J Budoff,Ronald P Karlsberg

Journal

Coronary Artery Disease

Published Date

2023/9/1

BackgroundArtificial intelligence (AI) applied to cardiac imaging may provide improved processing, reading precision and advantages of automation. Coronary artery calcium (CAC) score testing is a standard stratification tool that is rapid and highly reproducible. We analyzed CAC results of 100 studies in order to determine the accuracy and correlation between the AI software (Coreline AVIEW, Seoul, South Korea) and expert level-3 computed tomography (CT) human CAC interpretation and its performance when coronary artery disease data and reporting system (coronary artery calcium data and reporting system) classification is applied.MethodsA total of 100 non-contrast calcium score images were selected by blinded randomization and processed with the AI software versus human level-3 CT reading. The results were compared and the Pearson correlation index was calculated. The CAC-DRS classification …

Differences in left anterior descending coronary artery disease in participants without standard modifiable cardiovascular risk factors: the Multi-Ethnic Study of …

Authors

MP Gray,ST Vernon,MJ Budoff,GA Figtree

Journal

European Heart Journal

Published Date

2023/11

Background/Introduction The development of coronary artery disease (CAD) and myocardial infarction (MI) in the absence of standard modifiable cardiovascular risk factors (SMuRFs) has been highlighted as an unmet clinical need, accounting for between 10-27% of ST elevation MI and associated with higher 30-day mortality. One potential contributor to the early mortality is the higher observed rates of LAD territory culprit lesions in SMuRFless patients compared to those with at least one SMuRF. Purpose To characterise the differential proportion of LAD disease in an asymptomatic population with no prior cardiovascular disease (CVD) history, comparing individuals with CAD despite no SMuRFs to those with at least one SMuRF in the Multi-Ethnic Study of Atherosclerosis (MESA). Methods A MESA sub-cohort with a baseline coronary artery calcium score …

AI-Enabled Automated Cardiac Chambers Volumetry in ECG-Gated Coronary Calcium Scans vs. Non-Gated Lung Cancer Screening Scans

Authors

Morteza Naghavi,David Yankelevitz,Anthony Reeves,Matthew J Budoff,Chenyu Zhang,Kyle Atlas,Thomas Atlas,Claudia Henschke

Journal

Circulation

Published Date

2023/11/7

Introduction: We have developed an AI-enabled automated volume measurement of cardiac chambers (AutoChamber) that works on ECG-gated non-contrast coronary artery calcium scans and correlates well with contrast enhanced coronary CT angiography scans. Automated LA and LV volumes have shown to predict atrial fibrillation (Afib) and congestive heart failure. Hypothesis: In this study, we hypothesize that AutoChamber volumetry results in ECG-gated CAC scans correlated well with those of non-gated full-chest lung cancer screening scans in the same individuals. Methods: We have studied 169 cases of paired ECG-gated cardiac CT scans and non-gated lung scans. Mean±SD for age was 62±10 with 52% female. All caseswere asymptomatic and were scanned for preventive health assessment. AutoChamber was run on all cases by an independent operator who was not involvedin data analysis. P …

Predictors of non-calcified plaque presence and future adverse cardiovascular events in symptomatic rural Appalachian patients with a zero coronary artery calcium score

Authors

Tyler Miller,David Hana,Bansari Patel,Justin Conte,Dhivya Velu,Juan Carlo Avalon,Harshith Thyagaturu,Kesavan Sankaramangalam,Matthew Shotwell,Daniel Brito Guzman,Madhavi Kadiyala,Sudarshan Balla,Cathy Kim,Irfan Zeb,Brijesh Patel,Matthew Budoff,James Mills,Yasmin S Hamirani

Journal

Journal of Cardiovascular Computed Tomography

Published Date

2023/9/1

BackgroundCoronary artery calcium (CAC) scoring is a proven predictor for future adverse cardiovascular events (CVE) in asymptomatic individuals. Data is emerging regarding the usefulness of non-calcified plaque (NCP) assessment on cardiac computed tomography (CCT) angiography in symptomatic patients with a zero CAC score for further risk assessment.MethodsA retrospective review from January 2019 to January 2022 of 696 symptomatic patients with no known CAD and a zero CAC score identified 181 patients with NCP and 515 patients without NCP by a visual assessment on CCT angiography. The primary endpoint was to identify predictors for NCP presence and adverse CVEs (death, myocardial infarction, or cerebrovascular accident) within two years.ResultsBased on logistic regression, age (OR 1.039, 95% CI [1.020–1.058], p ​< ​0.001), diabetes mellitus (OR 2.192, 95% CI [1.307–3.676], p ​< …

Association of Iliac Artery Non-Calcified Plaque Volume and Acute Limb Ischemia: Insights From the VOYAGER PAD Angiographic Core Lab

Authors

Marc P Bonaca,Warren Capell,Cameron Tong,Tolulope Popoola,April Kinninger,Venkat Sanjay Manubolu,Manesh R Patel,Connie N Hess,Mark R Nehler,Sebastian Debus,Sonia S Anand,Lloyd P Haskell,Eva Muehlhofer,Michael Szarek,Matthew J Budoff

Journal

Circulation

Published Date

2023/11/7

Introduction/Background: Acute limb ischemia (ALI) is a severe complication of peripheral artery disease. Lipid lowering and antithrombotic therapies reduce ALI but pathologic studies have described thrombus in distal arteries without plaque, suggesting that artery to artery embolism from proximal (aortic-iliac) athero-thrombosis may be a key driver. Research Questions/Hypothesis: We hypothesized that the burden and character of atherosclerosis in the iliac arteries of patients with PAD would be associated with long term risk of ALI. Methods: VOYAGER PAD enrolled 6,554 patients with PAD and collected 2,200 baseline angiograms in 1,664 patients including 400 CT angiograms enabling plaque characterization. A case-control of 9 who had ALI during follow up and 9 controls were matched on anatomic and patient characteristics, type of index revascularization and disease pattern. Images were read by a blinded …

RELATIONSHIP BETWEEN SOCIOECONOMIC STATUS, CORONARY ARTERY CALCIUM AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: A MULTI-COHORT STUDY

Authors

Taylor Triana,Mark Berlacher,Karol Watson,Colby Ayers,Elaine Wu,Shreya Rao,Tiffany M Powell-Wiley,Ambarish Pandey,Parag Joshi,Michael P Bancks,Michael Blaha,Matthew Budoff,Amit Khera

Journal

American Journal of Preventive Cardiology

Published Date

2023/9/1

Therapeutic Area ASCVD/CVD Risk Assessment Background Low socioeconomic status (SES) is associated with atherosclerotic cardiovascular disease (ASCVD) and possible underestimation of risk by pooled cohort equations (PCE). Whether coronary artery calcium (CAC) scores can improve risk discrimination in low SES populations is unknown. Methods Multi-Ethnic Study of Atherosclerosis (MESA) and Dallas Heart Study (DHS) participants free of ASCVD and with CAC scans were evaluated. Low SES was defined as annual household income< $16,000 (vs. $16-$30,000,> $30,000) or educational attainment HS). The relationships between SES, CAC scores (0, 1-99,≥ 100), and ASCVD events (fatal/non-fatal MI or stroke) were assessed before/after ASCVD risk factor adjustment (Table). The incremental predictive value of CAC across SES groups was assessed using c-statistics and categorical net …

Presence of Ramus Intermedius Artery is Associated With Higher Atherosclerotic Plaque Burden in the Left Main Stem in Coronary CT Angiography

Authors

Leili Pourafkari,April Kinninger,Hooman Fazlalizadeh,Venkat Sanjay Manubolu,Sion Roy,Matthew J Budoff

Journal

Circulation

Published Date

2023/11/7

Introduction: Ramus intermedius (RI) is a variant vessel arising from left main (LM) bifurcation that supplies the lateral wall. It is thought that presence of RI would result in increased coronary turbulence in LM which in return could affect atherosclerotic plaque formation process. We aimed to investigate the association of presence of RI with presence of atherosclerotic plaque and stenosis in left main (LM). Hypothesis: Presence of RI artery associates with higher frequency of atherosclerotic plaque formation in LM Methods: We performed a large retrospective single-center study, including consecutive subjects who completed a CTA exam from October 2006 to December 2022 in Los Angeles, California to determine if presence of RI associated with higher LM coronary plaque burden. Chi-Square test was used to examine level of left main plaque burden and percent stenosis in subjects where the Ramus is present …

Aldosterone synthase inhibition with lorundrostat for uncontrolled hypertension: the target-HTN randomized clinical trial

Authors

Luke J Laffin,David Rodman,James M Luther,Anand Vaidya,Matthew R Weir,Natasa Rajicic,BT Slingsby,Steven E Nissen,Richard Beasley,Matthew Budoff,George Carr,Michael Carroll,Jose Cevallos Yepez,Anil Chhabra,Frank Cole,Leonard Dunn,William Eaves,Valentine Ebuh,Roger Estevez,Glenn Gould,Matthew Hong,Bruce Iteld,Mahendra Jain,Charles Kemp,Christina Kennelly,Mark Kleiner,Mark Kutner,Luke Laffin,Joseph Lambert,Gilbert Ledesma,Keung Lee,John Lentz,Steven Lupovitch,James Luther,Lon Lynn,Obadias Marquez,Mobeen Mazhar,David Morin,Joel Neutel,Yaa Oppong,Merlin Osorio,Andres Patron,Walter Pharr,Mercedes Ponce de Leon,Lilia Rodriguez-Ables,Jeffrey Rosen,Issac Sachmechi,Ronald Surowitz,Larkin Wadsworth,Jeffrey Wayne,Zahid Zafar,Target-HTN Investigators

Journal

Jama

Published Date

2023/9/26

ImportanceExcess aldosterone production contributes to hypertension in both classical hyperaldosteronism and obesity-associated hypertension. Therapies that reduce aldosterone synthesis may lower blood pressure.ObjectiveTo compare the safety and efficacy of lorundrostat, an aldosterone synthase inhibitor, with placebo, and characterize dose-dependent safety and efficacy to inform dose selection in future trials.Design, Setting, and ParticipantsRandomized, placebo-controlled, dose-ranging trial among adults with uncontrolled hypertension taking 2 or more antihypertensive medications. An initial cohort of 163 participants with suppressed plasma renin (plasma renin activity [PRA] ≤1.0 ng/mL/h) and elevated plasma aldosterone (≥1.0 ng/dL) were enrolled, with subsequent enrollment of 37 participants with PRA greater than 1.0 ng/mL/h.InterventionsParticipants were randomized to placebo or 1 of 5 dosages …

Coronary atherosclerosis across the Glycemic Spectrum among asymptomatic adults: the Miami heart Study at Baptist health South Florida

Authors

Kershaw V Patel,Matthew J Budoff,Javier Valero-Elizondo,Shubham Lahan,Shozab S Ali,Mohamad B Taha,Michael J Blaha,Ron Blankstein,Michael D Shapiro,Ambarish Pandey,Lara Arias,Theodore Feldman,Ricardo C Cury,Miguel Cainzos-Achirica,Svati H Shah,Jack A Ziffer,Jonathan Fialkow,Khurram Nasir

Journal

Circulation: Cardiovascular Imaging

Published Date

2023/10

BACKGROUND The contemporary burden and characteristics of coronary atherosclerosis, assessed using coronary computed tomography angiography (CCTA), is unknown among asymptomatic adults with diabetes and prediabetes in the United States. The pooled cohort equations and coronary artery calcium (CAC) score stratify atherosclerotic cardiovascular disease risk, but their association with CCTA findings across glycemic categories is not well established. METHODS Asymptomatic adults without atherosclerotic cardiovascular disease enrolled in the Miami Heart Study were included. Participants underwent CAC and CCTA testing and were classified into glycemic categories. Prevalence of coronary atherosclerosis (any plaque, noncalcified plaque, plaque with ≥1 high-risk feature, maximal stenosis ≥50%) assessed by CCTA was described across glycemic categories and further stratified by pooled …

Coronary Artery System Dominance Influences the Distribution of Calcified Plaques in Coronary Tree

Authors

Leili Pourafkari,April Kinninger,Venkat Sanjay Manubolu,Hooman Fazlalizadeh,Keishi Ichikawa,Jairo Aldana,Sion Roy,Matthew J Budoff

Journal

Circulation

Published Date

2023/11/7

Introduction: Left dominant coronary system associates with worse prognosis likely due to less well-balanced myocardial perfusion. Larger proportion of coronary flow enters left coronary in left dominant systems potentially leading to higher shear stress. In left dominant coronary systems, resultant alterations in flow hemodynamics could affect development of calcified plaques in left anterior descending artery (LAD). Hypothesis: Coronary artery dominance with resultant alterations in blood flow hemodynamics in coronary arteries could affect the distribution of calcified plaques in the coronary tree Methods: We performed a large retrospective single-center cohort study, including consecutive patients who underwent CTA from September 2006 to December 2022 in Los Angeles, California to determine whether left dominant coronary anatomy was associated with higher LAD calcium percentage (LAD calcium score …

Cardiovascular Testing in the United States during the COVID-19 Pandemic: Volume Recovery and Worldwide Comparison.

Authors

Renee Bullock-Palmer,Marcus Chen,Michael DiLorenzo,Rami Doukky,Maros Ferencik,Jeffrey Geske,Fadi Hage,Robert Hendel,Lynne Koweek,Venkatesh Murthy,Jagat Narula,Patricia Rodriguez Lozano,Nishant Shah,Amee Shah,Prem Soman,Randall Thompson,David Wolinsky,Yosef Cohen,Eli Malkovskiy,Michael Randazzo,Juan Lopez-Mattei,Purvi Parwani,Mrinali Shetty,Thomas Pascual,Yaroslav Pynda,Maurizio Dondi,Diana Paez,Andrew Einstein,Cole Hirschfeld,Sharmila Dorbala,Leslee Shaw,Todd Villines,Andrew Choi,Nathan Better,Rodrigo Cerci,Ganesan Karthikeyan,João Vitola,Michelle Williams,Mouaz Al-Mallah,Daniel Berman,Adam Bernheim,Robert Biederman,Paco Bravo,Matthew Budoff

Journal

Radiology: Cardiothoracic Imaging

Published Date

2023/10/1

PURPOSE To characterize the recovery of diagnostic cardiovascular procedure volumes in U.S. and non-U.S. facilities in the year following the initial COVID-19 outbreak. MATERIALS AND METHODS The International Atomic Energy Agency (IAEA) coordinated a worldwide study called the IAEA Noninvasive Cardiology Protocols Study of COVID-19 2 (INCAPS COVID 2), collecting data from 669 facilities in 107 countries, including 93 facilities in 34 U.S. states, to determine the impact of the pandemic on diagnostic cardiovascular procedure volumes. Participants reported volumes for each diagnostic imaging modality used at their facility for March 2019 (baseline), April 2020, and April 2021. This secondary analysis of INCAPS COVID 2 evaluated differences in changes in procedure volume between U.S. and non-U.S. facilities and among U.S. regions. Factors associated with return to prepandemic volumes in the United States were also analyzed in a multivariable regression analysis. RESULTS Reduction in procedure volumes in April 2020 compared with baseline was similar for U.S. and non-U.S. facilities (-66% vs -71%, P = .27). U.S. facilities reported greater return to baseline in April 2021 than did all non-U.S. facilities (4% vs -6%, P = .008), but there was no evidence of a difference when comparing U.S. facilities with non-U.S. high-income country (NUHIC) facilities (4% vs 0%, P = .18). U.S. regional differences in return to baseline were observed between the Midwest (11%), Northeast (9%), South (1%), and West (-7%, P = .03), but no studied factors were significant predictors of 2021 change from prepandemic baseline. CONCLUSION The …

Whole-genome sequencing uncovers two loci for coronary artery calcification and identifies ARSE as a regulator of vascular calcification

Authors

Paul S de Vries,Matthew P Conomos,Kuldeep Singh,Christopher J Nicholson,Deepti Jain,Natalie R Hasbani,Wanlin Jiang,Sujin Lee,Christian L Lino Cardenas,Sharon M Lutz,Doris Wong,Xiuqing Guo,Jie Yao,Erica P Young,Catherine Tcheandjieu,Austin T Hilliard,Joshua C Bis,Lawrence F Bielak,Michael R Brown,Shaila Musharoff,Shoa L Clarke,James G Terry,Nicholette D Palmer,Lisa R Yanek,Huichun Xu,Nancy Heard-Costa,Jennifer Wessel,Margaret Sunitha Selvaraj,Rebecca H Li,Xiao Sun,Adam W Turner,Adrienne M Stilp,Alyna Khan,Anne B Newman,Asif Rasheed,Barry I Freedman,Brian G Kral,Caitlin P McHugh,Chani Hodonsky,Danish Saleheen,David M Herrington,David R Jacobs Jr,Deborah A Nickerson,Eric Boerwinkle,Fei Fei Wang,Gerardo Heiss,Goo Jun,Greg L Kinney,Haakon H Sigurslid,HarshaVardhan Doddapaneni,Ira M Hall,Isabela M Bensenor,Jai Broome,James D Crapo,James G Wilson,Jennifer A Smith,John Blangero,Jose D Vargas,Jose Verdezoto Mosquera,Joshua D Smith,Karine A Viaud-Martinez,Kathleen A Ryan,Kendra A Young,Kent D Taylor,Leslie A Lange,Leslie S Emery,Marcio S Bittencourt,Matthew J Budoff,May E Montasser,Miao Yu,Michael C Mahaney,Mohammed S Mahamdeh,Myriam Fornage,Nora Franceschini,Paulo A Lotufo,Pradeep Natarajan,Quenna Wong,Rasika A Mathias,Richard A Gibbs,Ron Do,Roxana Mehran,Russell P Tracy,Ryan W Kim,Sarah C Nelson,Scott M Damrauer,Sharon LR Kardia,Stephen S Rich,Valentin Fuster,Valerio Napolioni,Wei Zhao,Wenjie Tian,Xianyong Yin,Yuan-I Min,Alisa K Manning,Gina Peloso,Tanika N Kelly,Christopher J O’Donnell,Alanna C Morrison,Joanne E Curran,Warren M Zapol,Donald W Bowden,Lewis C Becker,Adolfo Correa,Braxton D Mitchell,Bruce M Psaty,John Jeffrey Carr,Alexandre C Pereira,Themistocles L Assimes,Nathan O Stitziel,John E Hokanson,Cecelia A Laurie,Jerome I Rotter,Ramachandran S Vasan,Wendy S Post,Patricia A Peyser,Clint L Miller,Rajeev Malhotra

Journal

Nature Cardiovascular Research

Published Date

2023/12

Coronary artery calcification (CAC) is a measure of atherosclerosis and a well-established predictor of coronary artery disease (CAD) events. Here we describe a genome-wide association study of CAC in 22,400 participants from multiple ancestral groups. We confirmed associations with four known loci and identified two additional loci associated with CAC (ARSE and MMP16), with evidence of significant associations in replication analyses for both novel loci. Functional assays of ARSE and MMP16 in human vascular smooth muscle cells (VSMCs) demonstrate that ARSE is a promoter of VSMC calcification and VSMC phenotype switching from a contractile to a calcifying or osteogenic phenotype. Furthermore, we show that the association of variants near ARSE with reduced CAC is likely explained by reduced ARSE expression with the G allele of enhancer variant rs5982944. Our study highlights ARSE as an …

Regression and stabilization of atherogenic plaques.

Authors

Jairo Aldana-Bitar,Deepak L Bhatt,Matthew J Budoff

Published Date

2023/7/24

Atherosclerotic plaque assessment has become a crucial element in the examination of cardiovascular diseases. Plaque may exhibit progression and could become unstable if not treated, making plaque regression and stabilization among the most important goals of any cardiovascular intervention in cardiovascular medicine. In this review, we explore the current understanding of plaque regression and stabilization, discuss imaging and measurement techniques, and examine the evidence for pharmacological interventions and other interventions aimed at addressing this condition.

Prognostic value of coronary artery calcium score for the prediction of atherosclerotic cardiovascular disease in participants with suspected nonalcoholic hepatic steatosis …

Authors

Kongkiat Chaikriangkrai,Ghanshyam Palamaner Subash Shantha,Hye Yeon Jhun,Patompong Ungprasert,Gardar Sigurdsson,Faisal Nabi,John J Mahmarian,Su Min Chang

Published Date

2016/12/1

Study objectiveCoronary artery calcium score (CACS) is a well-established test for risk stratifying asymptomatic patients. Recent studies also indicate that CACS may accurately risk stratify stable patients presenting to the emergency department (ED) with acute chest pain; however, many were underpowered. The purpose of this systematic review and meta-analysis is to evaluate the prognostic value and accuracy of a zero (normal) CACS for identifying patients at acceptable low risk for future cardiovascular events who might be safely discharged home from the ED.MethodsWe searched multiple databases for longitudinal studies of CACS in symptomatic patients without known coronary artery disease that reported major adverse cardiovascular events (MACEs), including death and myocardial infarction. Pooled risk ratios, sensitivity, specificity, and likelihood ratios were analyzed.ResultsEight studies evaluated 3 …

Association of Inflammation and Lipoprotein (a) With Aortic Valve Calcification

Authors

Natalie Marrero,Alexander C Razavi,Ellen Boakye,Khalil Anchouche,Zeina Dardari,Omar Dzaye,Kunal Jha,Matthew J Budoff,Michael Y Tsai,Jerome I Rotter,Roger S Blumenthal,George Thanassoulis,Wendy S Post,Michael J Blaha,Seamus P Whelton

Journal

Cardiovascular Imaging

Published Date

2023/4/12

Although aortic valve calcification (AVC) is a key component in aortic stenosis (AS), the pathophysiology underlying AVC remains incompletely understood. Lipoprotein (a)(Lp [a]), an atherogenic and proinflammatory lipoprotein, and high-sensitivity C-reactive protein (hsCRP), a measure of inflammation, both contribute to AVC. Lp (a) and hsCRP have a significant interaction in the context of atherosclerotic cardiovascular disease, but whether these risk factors have an interaction with regard to AVC remains unknown. 1, 2A total of 6,676 participants 45 to 84 years of age without overt cardiovascular disease had cardiac computed tomography (CT) performed at visit 1 (2000-2002) of the MESA (Multi-Ethnic Study of Atherosclerosis) study. The MESA protocol was approved by the Institutional Review Boards at the participating institutions, and written informed consent was obtained from all participants. Noncontrast …

Low HDL cholesterol and hyperglicemia are metabolic syndrome components associated with plaque progression in patients with chronic coronary syndrome: a PARADIGM study

Authors

D Neglia,C Caselli,E Maffei,SE Lee,JM Sung,D Andreini,M Al-Mallah,MJ Budoff,I Gottlieb,M Hadamitzky,H Marques,JK Min,F Cademartiri,HJ Chang

Journal

European Heart Journal

Published Date

2023/11

Background The metabolic syndrome (MetS), a cluster of dyslipidemia, hyperglicemia and hypertension predicts future cardiovascular disease and death in general populations. Purpose We aimed to assess whether MetS and its components may impact on coronary plaque progression (PP), at serial coronary computed tomography angiography (CCTA), and major adverse cardiovascular events (MACE) in patients with chronic coronary syndrome (CCS). Methods A total of 1200 CCS patients (aged 60.9±9.3 years, 55.4% male) who underwent serial CCTA (≥2 years apart) and had available data on glucose/lipid metabolism and outcome, were analysed from the Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography IMaging (PARADIGM) registry. MetS and its components were categorized according to NCEPT ATPIII …

Mitral annular calcification as a predictor of stroke in the multiethnic study of atherosclerosis

Authors

Afiachukwu Onuegbu,Francesca Calicchio,April Kinninger,Rine Nakanishi,John J Carr,Khurram Nasir,Rebecca Gottesman,Matthew Budoff

Published Date

2023/9/1

BackgroundMitral annular calcification (MAC) is associated with an increased risk for cardiovascular morbidity and mortality. This study provides recent data on the association between cardiac computed tomography (CT) derived MAC and 15 years of stroke risk in a racially diverse cohort.MethodsAll multiethnic studies of atherosclerosis participants (n= 6814) who completed a cardiac CT at baseline were included in this analysis. MAC score was calculated from cardiac CT using the Agatston and volume score methods. Multivariable Cox proportional hazard regression models were used to compute hazard ratios for the association between MAC and stroke after adjusting for traditional cardiovascular risk factors, inflammatory markers, coronary artery calcium score, atrial fibrillation, and left atrial size.ResultsOverall, 9% of participants (644/6814) had MAC at baseline. Over a surveillance period of 15 years, 304 …

A Deep Learning Algorithm to Estimate Left Ventricular Mass From Coronary Calcium CT Scans: Association With Incident Heart Failure Events From the Dallas Heart Study

Authors

Shawn Simek,Fernando Kay,Suhny Abbara,MD,Colby Ayers,Sonia Garg,Ambarish Pandey,Anand Rohatgi,Amit Khera,Mark H Drazner,Matthew J Budoff,James A de Lemos,Ronald M Peshock,Parag H Joshi

Journal

Circulation

Published Date

2023/11/7

Introduction: Coronary artery calcium CT (CAC-CT) scans used for ASCVD risk prediction may contain additional clinical information that is currently underexploited. We developed a novel deep-learning algorithm to estimate LV mass from CAC-CT (CT-LVM) and analyzed associations with cardiac biomarkers and incident CV outcomes in the Dallas Heart Study (DHS). Hypothesis: Higher CT-LVM will be associated with baseline cardiac biomarker elevations (hsTnT and NT-proBNP) and a higher risk of incident CVD (heart failure, MI, stroke, and all-cause death). Methods: We included 1841 DHS phase 2 participants (mean age 50, 59% female, 46% Black race) who were free of baseline CVD and underwent CAC-CT and cardiac MRI. Our novel deep-learning algorithm features automatic cardiac chamber segmentation via a 3D U-Net architecture on CAC-CT, followed by a 3D DenseNet model to predict LV mass …

Coronary Artery Calcium and All-Cause Mortality in the Multicenter Aids Cohort Study: MACS

Authors

Takahiro Suzuki,Sabina Haberlen,Tess E Peterson,Frank Palella,Matthew Budoff,Mallory D Witt,Jared W Magnani,Wendy S Post

Journal

Circulation

Published Date

2023/11/7

Introduction: People living with HIV (PLWH) have more subclinical cardiovascular disease than people without HIV (PWOH), but few studies have evaluated risk for mortality based on coronary artery calcium (CAC) among this population. Purpose: This study aimed to determine the association between CAC and all-cause mortality among male PLWH and PWOH and to identify a potential interaction with HIV serostatus. Methods: The study population was derived from the MACS, a US prospective observational cohort study including male PLWH and PWOH. Participants underwent cardiac non-contrast computed tomography from July 2004 to November 2013. Men with atrial fibrillation, coronary heart disease, or coronary revascularization were excluded. Cox proportional hazards model was used to calculate adjusted hazard ratios [aHR] for all-cause mortality among men with vs. without baseline CAC (Agatston …

The True Power of Zero

Authors

Matthew J Budoff

Journal

Cardiovascular Imaging

Published Date

2023/9/1

I read with great interest the study by Agha et al 1 on the utility and predictive power of a coronary artery calcium (CAC) score of zero: a simple test, taking< 1 minute to acquire, without needles, injections, iodinated contrast, or exercise, to determine how much calcified atherosclerotic plaque an individual has. This simple metric, now used for coronary artery disease (CAD) detection, much as a mammogram is used for breast cancer, allows us to identify, with high sensitivity, the presence of obstructive CAD and future CAD events. This paper is the most comprehensive review of CAC to date, studying 19 papers comprising 79,903 patients with stable chest pain and 13 papers including 12,376 patients with acute chest pain undergoing simultaneous CAC and coronary computed tomography angiography (CTA) assessment.However, the biggest flaw of this paper 1 is the exclusion of the studies that used cardiac …

Association of Retinal Microvascular Changes With Incidence and Progression of Coronary Artery Calcium Score in Individuals With vs Without Diabetes Mellitus; Data From the …

Authors

bahram khazai,Fatemeh Adabifirouzjaei,Mengye Guo,Eli Ipp,Ronald Klein,Barbara Klein,Mary Frances Cotch,Tien Y Wong,Ronald Swerdloff,Christina Wang,Prasanth Surampudi,Joel D Kaufman,Claire Park,Robert C C Hendel,Matthew J Budoff

Journal

Circulation

Published Date

2023/11/7

Introduction: Retinopathy (RP) is a microvascular complication of diabetes mellitus (DM); however, it is also increasingly recognized in persons without DM. Microvascular disease may play a prominent role in coronary heart disease (CHD) development. We performed this study to evaluate the association of grades of RP with incidence of CAC (Coronary Artery Calcium) among those with zero CAC at baseline. Hypothesis: We performed this study to evaluate the association of grades of RP with incidence of CAC among those with zero CAC at baseline and to Identify the association of grades of MA and RP with progression of CAC among those with positive CAC at baseline. Methods: We included 5709 subjects with and without DM from the Multi-Ethnic Study of Atherosclerosis (MESA), who had retinal photos and CAC score available. We analyzed the association of grades of RP with incidence and progression of …

Progression of non-obstructive coronary plaque: a practical CCTA-based risk score from the PARADIGM registry

Authors

Gianluca Pontone,Alexia Rossi,Andrea Baggiano,Daniele Andreini,Edoardo Conte,Laura Fusini,Chaterine Gebhard,Mark G Rabbat,Andrea Guaricci,Marco Guglielmo,Giuseppe Muscogiuri,Saima Mushtaq,Mouaz H Al-Mallah,Daniel S Berman,Matthew J Budoff,Filippo Cademartiri,Kavitha Chinnaiyan,Jung Hyun Choi,Eun Ju Chun,Pedro de Araújo Gonçalves,Ilan Gottlieb,Martin Hadamitzky,Yong Jin Kim,Byoung Kwon Lee,Sang-Eun Lee,Erica Maffei,Hugo Marques,Habib Samady,Sanghoon Shin,Ji Min Sung,Alexander van Rosendael,Renu Virmani,Jeroen J Bax,Jonathon A Leipsic,Fay Y Lin,James K Min,Jagat Narula,Leslee J Shaw,Hyuk-Jae Chang

Journal

European radiology

Published Date

2023/9/26

ObjectivesNo clear recommendations are endorsed by the different scientific societies on the clinical use of repeat coronary computed tomography angiography (CCTA) in patients with non-obstructive coronary artery disease (CAD). This study aimed to develop and validate a practical CCTA risk score to predict medium-term disease progression in patients at a low-to-intermediate probability of CAD.MethodsPatients were part of the Progression of AtheRosclerotic PlAque Determined by Computed Tomographic Angiography Imaging (PARADIGM) registry. Specifically, 370 (derivation cohort) and 219 (validation cohort) patients with two repeat, clinically indicated CCTA scans, non-obstructive CAD, and absence of high-risk plaque (≥ 2 high-risk features) at baseline CCTA were included. Disease progression was defined as the new occurrence of ≥ 50% stenosis and/or high-risk plaque at follow-up CCTA.Results …

Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification

Authors

Maryam Kavousi,Maxime M Bos,Hanna J Barnes,Christian L Lino Cardenas,Doris Wong,Haojie Lu,Chani J Hodonsky,Lennart PL Landsmeer,Adam W Turner,Minjung Kho,Natalie R Hasbani,Paul S de Vries,Donald W Bowden,Sandesh Chopade,Joris Deelen,Ernest Diez Benavente,Xiuqing Guo,Edith Hofer,Shih-Jen Hwang,Sharon M Lutz,Leo-Pekka Lyytikäinen,Lotte Slenders,Albert V Smith,Maggie A Stanislawski,Jessica van Setten,Quenna Wong,Lisa R Yanek,Diane M Becker,Marian Beekman,Matthew J Budoff,Mary F Feitosa,Chris Finan,Austin T Hilliard,Sharon LR Kardia,Jason C Kovacic,Brian G Kral,Carl D Langefeld,Lenore J Launer,Shaista Malik,Firdaus AA Mohamed Hoesein,Michal Mokry,Reinhold Schmidt,Jennifer A Smith,Kent D Taylor,James G Terry,Jeroen van der Grond,Joyce van Meurs,Rozemarijn Vliegenthart,Jianzhao Xu,Kendra A Young,Nuno R Zilhão,Robert Zweiker,Themistocles L Assimes,Lewis C Becker,Daniel Bos,J Jeffrey Carr,L Adrienne Cupples,Dominique P v de Kleijn,Menno de Winther,Hester M den Ruijter,Myriam Fornage,Barry I Freedman,Vilmundur Gudnason,Aroon D Hingorani,John E Hokanson,M Arfan Ikram,Ivana Išgum,David R Jacobs Jr,Mika Kähönen,Leslie A Lange,Terho Lehtimäki,Gerard Pasterkamp,Olli T Raitakari,Helena Schmidt,P Eline Slagboom,André G Uitterlinden,Meike W Vernooij,Joshua C Bis,Nora Franceschini,Bruce M Psaty,Wendy S Post,Jerome I Rotter,Johan LM Björkegren,Christopher J O’Donnell,Lawrence F Bielak,Patricia A Peyser,Rajeev Malhotra,Sander W van der Laan,Clint L Miller

Journal

Nature genetics

Published Date

2023/10

Coronary artery calcification (CAC), a measure of subclinical atherosclerosis, predicts future symptomatic coronary artery disease (CAD). Identifying genetic risk factors for CAC may point to new therapeutic avenues for prevention. Currently, there are only four known risk loci for CAC identified from genome-wide association studies (GWAS) in the general population. Here we conducted the largest multi-ancestry GWAS meta-analysis of CAC to date, which comprised 26,909 individuals of European ancestry and 8,867 individuals of African ancestry. We identified 11 independent risk loci, of which eight were new for CAC and five had not been reported for CAD. These new CAC loci are related to bone mineralization, phosphate catabolism and hormone metabolic pathways. Several new loci harbor candidate causal genes supported by multiple lines of functional evidence and are regulators of smooth muscle cell …

Coronary Artery Calcium for Risk Stratification Among Persons With Very-High High-Density Lipoprotein Cholesterol

Authors

Alexander C Razavi,Anurag Mehta,Matthew J Budoff,Eugenia Gianos,Nathan Wong,Viola Vaccarino,Marly Van Assen,Carlo N De,Alan Rozanski,Michael Miedema,John A Rumberger,Martin B Mortensen,Leslee J Shaw,Khurram Nasir,Roger S Blumenthal,Anand Rohatgi,Arshed A Quyyumi,Laurence Sperling,Seamus P Whelton,Michael J Blaha,Daniel Berman,Omar Dzaye

Journal

Circulation

Published Date

2023/11/6

Introduction: Persons with very-high high-density lipoprotein-cholesterol (HDL-C) may experience an increased mortality risk. However, the predictors of mortality among those with very-high HDL-C remain unknown. Hypothesis: Compared to traditional risk factors, coronary artery calcium (CAC) will more strongly stratify risk among individuals with very-high HDL-C. Aims: Among individuals with very-high HDL-C, to 1) calculate crude all-cause mortality rates across the burden of traditional risk factors and CAC, and 2) identify independent risk factors associated with all-cause mortality. Methods: There were 335 primary prevention patients from the CAC Consortium who had very-high HDL-C (>80 mg/dL in men, >100 mg/dL in women) and available information on traditional CVD risk factors. Crude all-cause mortality rates were calculated per 1,000 person-years. Multivariable Cox proportional hazards regression …

Subclinical coronary atherosclerosis and risk for myocardial infarction in a Danish Cohort

Authors

Matthew J Budoff,Khurram Nasir,Michael J Blaha

Journal

Annals of internal medicine

Published Date

2023/10

TO THE EDITOR: We read with interest Fuchs and colleagues' study (1) on the use of coronary computed tomography angiography (CTA), because data on outcomes after this study in asymptomatic cohorts are limited. We applaud the authors for their large and robust study with blinding to coronary CTA results, which ensured approximation of a natural history study.Following 9533 asymptomatic participants for 3.5 years, the authors show that both extensive plaque and obstructive coronary artery disease (evaluated using visual assessment) are predictors of myocardial infarction and mortality. They lay the groundwork for use of coronary CTA for risk stratification of...

CT-derived pectoralis composition and incident pneumonia hospitalization using fully automated deep-learning algorithm: multi-ethnic study of atherosclerosis

Authors

Hamza A Ibad,Quincy A Hathaway,David A Bluemke,Arta Kasaeian,Joshua G Klein,Matthew J Budoff,R Graham Barr,Matthew Allison,Wendy S Post,João AC Lima,Shadpour Demehri

Journal

European radiology

Published Date

2023/11/11

BackgroundPneumonia-related hospitalization may be associated with advanced skeletal muscle loss due to aging (i.e., sarcopenia) or chronic illnesses (i.e., cachexia). Early detection of muscle loss may now be feasible using deep-learning algorithms applied on conventional chest CT.ObjectivesTo implement a fully automated deep-learning algorithm for pectoralis muscle measures from conventional chest CT and investigate longitudinal associations between these measures and incident pneumonia hospitalization according to Chronic Obstructive Pulmonary Disease (COPD) status.Materials and methodsThis analysis from the Multi-Ethnic Study of Atherosclerosis included participants with available chest CT examinations between 2010 and 2012. We implemented pectoralis muscle composition measures from a fully automated deep-learning algorithm (Mask R-CNN, built on the Faster Region Proposal …

TESTOSTERONE REPLETEMENT: Is it the TRAVERSE Trial or a Travesty?

Authors

Matthew J Budoff

Published Date

2023/12/1

There is a paper published that did not put its limitations into perspective and may lead to false reassurance about the safety of testosterone, recently published in the New England Journal of Medicine. 1 This trial was done to demonstrate cardiovascular safety of testosterone repletement in men with low testosterone and symptoms. The authors concluded “Among 5,198 patients who received testosterone or placebo for a mean duration of 22 months, testosterone-replacement therapy was noninferior to placebo with respect to the incidence of major adverse cardiac events”. 1Unfortunately, the trial was truncated early, didn’t achieve adequate repletement of testosterone, and had a majority (> 60%) of participants discontinue therapy during follow-up. According to the study design paper,“Approximately 6,000 subjects will be randomized to either 1.62% transdermal testosterone gel or a matching placebo gel daily for …

Efficacy and Safety of Iodixanol in Computed Coronary Tomographic Angiography and Cardiac Catheterization

Authors

Matthew J Budoff,Hong Seok Lee,Sion K Roy,Chandana Shekar

Published Date

2023/10/31

Iodixanol is an iso-osmolar non-ionic dimeric hydrophilic contrast agent with a higher viscosity than the monomeric agents. It is the only Food and Drug Administration (FDA)-approved iso-osmolar agent in the United States, and it is the only contrast agent with an FDA-approved indication for use in cardiac computed tomographic angiography (CCTA), to assist in the diagnostic evaluation of patients with suspected coronary artery disease. In clinical studies, it has been noted to have fewer side effects and similar image quality when compared to low-osmolar contrast media. This can be attributed to the pharmacological properties of iodixanol. These contrast agents are used for coronary computed tomography angiography and cardiac catheterization. In this article, the use, tolerability, and efficacy of iodixanol are reviewed, specifically evaluating the use of CCTA and coronary angiography, including outcome studies, randomized trials, and comparisons to other contrast agents.

Plasma Trimethylamine‐N‐Oxide and Incident Ischemic Stroke: The Cardiovascular Health Study and the Multi‐Ethnic Study of Atherosclerosis

Authors

Rozenn N Lemaitre,Paul N Jensen,Zeneng Wang,Amanda M Fretts,Colleen M Sitlani,Ina Nemet,Nona Sotoodehnia,Marcia C de Oliveira Otto,Weifei Zhu,Matt Budoff,WT Longstreth,Bruce M Psaty,David S Siscovick,Stanley L Hazen,Dariush Mozaffarian

Journal

Journal of the American Heart Association

Published Date

2023/8/15

Background The association of circulating trimethylamine‐N‐oxide (TMAO) with stroke has received limited attention. To address this gap, we examined the associations of serial measures of plasma TMAO with incident ischemic stroke. Methods and Results We used a prospective cohort design with data pooled from 2 cohorts. The settings were the CHS (Cardiovascular Health Study), a cohort of older adults, and the MESA (Multi‐Ethnic Study of Atherosclerosis), both in the United States. We measured plasma concentrations of TMAO at baseline and again during the follow‐up using high‐performance liquid chromatography and mass spectrometry. We assessed the association of plasma TMAO with incident ischemic stroke using proportional hazards regression adjusted for risk factors. The combined cohorts included 11 785 participants without a history of stroke, on average 73 (CHS) and 62 (MESA) years old …

Inter-and intra-observer reproducibility of CT-Leaman score by an independent core lab

Authors

Pruthvi C Revaiah,Shigetaka Kageyama,Shinichiro Masuda,Kai Ninomiya,Nozomi Kotoku,Bo Wang,Xingqiang He,Tsung-Ying Tsai,Scot Garg,Saima Mushtaq,Johan HC Reiber,David M Leaman,Jeroen J Bax,Matthew J Budoff,Daniele Andreini,Patrick W Serruys,Yoshinobu Onuma

Journal

The International Journal of Cardiovascular Imaging

Published Date

2023/11

To assess the reproducibility of CT-based Leaman score (CT-LeSc). CT-LeSc can non-invasively quantify total coronary atherosclerotic burden and is an independent long-term predictor of cardiac events. Its calculation however relies on the subjective assessment of lesions using coronary computed tomography angiography and therefore is subject to intra- and inter-observer variability. Inter-observer reproducibility was assessed by calculating the CT-LeSc in 50 patients randomly selected from the SYNTAX III REVOLUTION and ABSORB trials by two separate teams, each made up of two cardiologists, who reported results by consensus. For intra-observer reproducibility, the CT-LeSc was calculated in same 50 patients on two occasions eight weeks apart, by the same team of two cardiologists. The level of agreement was measured by the weighted kappa statistic, with intra- and inter-observer variability used to …

When does a calcium score equate to secondary Prevention? Insights from the multinational CONFIRM Registry

Authors

Matthew J Budoff,April Kinninger,Heidi Gransar,Stephan Achenbach,Mouaz Al-Mallah,Jeroen J Bax,Daniel S Berman,Filippo Cademartiri,Tracy Q Callister,Hyuk-Jae Chang,Benjamin JW Chow,Ricardo C Cury,Gudrun Feuchtner,Martin Hadamitzky,Joerg Hausleiter,Philipp A Kaufmann,Jonathon Leipsic,Fay Y Lin,Yong-Jin Kim,Hugo Marques,Gianluca Pontone,Ronen Rubinshtein,Leslee J Shaw,Todd C Villines,James K Min,CONFIRM Investigators

Journal

Cardiovascular Imaging

Published Date

2023/9/1

Background Elevated coronary artery calcium (CAC) scores in subjects without prior atherosclerotic cardiovascular disease (ASCVD) have been shown to be associated with increased cardiovascular risk. Objectives The authors sought to determine at what level individuals with elevated CAC scores who have not had an ASCVD event should be treated as aggressively for cardiovascular risk factors as patients who have already survived an ASCVD event. Methods The authors performed a cohort study comparing event rates of patients with established ASVCD to event rates in persons with no history of ASCVD and known calcium scores to ascertain at what level elevated CAC scores equate to risk associated with existing ASCVD. In the multinational CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter) registry, the authors compared ASCVD event rates in persons …

Artificial Intelligence Guided Coronary CT Angiography Impacts Care Beyond Conventional Assessment: The CERTAIN Trial

Authors

Nick Nurmohamed,Jason H Cole,Matthew J Budoff,Ronald P Karlsberg,Himanshu Gupta,Lance Sullenberger,Carlos Quesada,Habib Rahban,Kevin Woods,Jeffrey Uzzilia,Scott Purga,Melissa Aquino,James K Min,James Earls,Andrew Choi

Journal

Circulation

Published Date

2023/11/7

Background: Atherosclerosis imaging-quantitative CT angiography (AI-QCT) guided by artificial intelligence has demonstrated high diagnostic accuracy for assessment of coronary atherosclerosis, stenosis and ischemia (AI-QCTISCHEMIA). Methods: CERTAIN was a multicenter study in 5 expert US centers prospectively recruiting 775 consecutive adult patients referred for CCTA. First, physicians were asked to complete an assessment of the patients’ diagnosis, additional imaging plan, intervention plan and medication management plan based on the conventional site assessment. Subsequently, coronary CT angiography (CCTA) exams were analyzed using AI-QCT, after which physicians were asked to repeat the assessment. Results: The 775 patients had a mean age of 64±12 years, 304 (39%) were female. Compared to site CCTA, AI-QCT analysis improved physician’s complete confidence two- to fivefold in …

Defining Demographic-specific Coronary Artery Calcium Percentiles in the Population Aged≥ 75: The ARIC Study and MESA

Authors

Frances M Wang,Miguel Cainzos-Achirica,Shoshana H Ballew,Josef Coresh,Aaron R Folsom,Candace M Howard,Wendy S Post,Lynne E Wagenknecht,Matthew J Budoff,Michael J Blaha,Kunihiro Matsushita

Journal

Circulation: Cardiovascular Imaging

Published Date

2023/9

BACKGROUND Current clinical guidelines recommend a coronary artery calcium (CAC) score of 100 Agatston Units or demographic-specific 75th percentile as high-risk thresholds for guiding atherosclerotic cardiovascular disease preventive therapy. Meanwhile, low CAC can help derisk individuals who may safely defer statin therapy. However, limited data from the early 2000s, including just 208 older Black individuals, inform CAC percentiles for adults aged 75 to 85 years, and none have been established in adults aged ≥85 years. This study aims to characterize the distribution of CAC and establish demographic-specific CAC percentiles in the population aged ≥75 years. METHODS We assessed 2886 participants aged ≥75 years without clinical coronary heart disease from the ARIC study (Atherosclerosis Risk in Communities) visit 7 (2018–2019; n=2217) and the MESA (Multi-Ethnic Study of …

The Multi-Ethnic Association of Aortic Valve Calcium and Long-Term Risk of Incident Severe Aortic Stenosis: Multi-Ethnic Study of Atherosclerosis

Authors

Jelani K Grant,Kunal Jha,Natalie Marrero,Alexander C Razavi,Ellen Boakye,Khalil Anchouche,Omar Dzaye,Matthew Budoff,Sanjiv J Shah,Matthew J Czarny,Jerome I Rotter,Xiuqing Guo,Jie Yao,Roger S Blumenthal,George Thanassoulis,Wendy S Post,Michael J Blaha,Seamus P Whelton

Journal

Circulation

Published Date

2023/11/6

Introduction: Racial/ethnic differences exist in the prevalence and burden of aortic valve calcium (AVC) and in the incidence of aortic stenosis (AS). While AVC is strongly associated with the long-term risk for AS, whether this association differs by race/ethnicity remains uncertain. Hypothesis: There will be a similar absolute event rate for incident moderate to severe AS within AVC categories across race/ethnicity. Methods: 6,812 MESA participants underwent non-contrast EKG gated CT at MESA Visit 1 and AVC was quantified using the Agatston scoring method. Adjudication of incident moderate and severe AS was defined using standard clinical criteria. We assessed the association of AVC with the combined outcome of incident moderate-severe AS stratified by race/ethnicity. We calculated the event rate per 1,000 person-years and multivariate Cox proportional hazards with log-transformed AVC as a continuous …

Letter by Aldana-Bitar et al Regarding Article,“Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients With Familial Hypercholesterolemia: The ARCHITECT Study”

Authors

Jairo Aldana-Bitar,Ronald P Karlsberg,Matthew J Budoff

Journal

Circulation

Published Date

2023/9/26

Letter by Aldana-Bitar et al Regarding Article, “Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients With Familial Hypercholesterolemia: The ARCHITECT Study” | Circulation Science Volunteer Warning signs SearchSearch Advanced Search Donate Circulation logo Hello Guest! MY ALERTS SIGN IN JOIN OpenAthens/Shibboleth » Submit your article AHA Logo SearchSearch Skip main navigation Close Drawer MenuOpen Drawer Menu Home AHA Journals AHA Journals Home Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB) Journal Home Current Issue See All Issues Circulation Journal Home Current Issue See All Issues Circ: Arrhythmia and Electrophysiology Journal Home Current Issue See All Issues Circ: Genomic and Precision Medicine Journal Home Current Issue See All Issues Circ: Cardiovascular Imaging Journal Home Current Issue See All Issues Circ: Cardiovascular …

Cardiac Computed Tomography Variables for Prediction of New-Onset Heart Failure: Multi-Ethnic Study of Atherosclerosis

Authors

Angelo L de la Rosa,Aditya Mehta,Spencer L Hansen,Robyn L McClelland,Alain G Bertoni,Matthew J Budoff

Journal

Circulation

Published Date

2023/11/7

Introduction: Heart failure (HF) prediction models utilize clinical variables. The purpose of this study was to determine if addition of cardiac computed tomography (CT) variables could improve discrimination of HF prediction scores. Methods: Participants of the Multi-Ethnic Study of Atherosclerosis (MESA), a cohort between 45 to 84 years old and free of clinical cardiovascular disease at baseline, with complete clinical data and cardiac CT were included to evaluate new-onset HF during the follow-up period. Cardiac CT variables analyzed included left ventricular size index (LVSi) and calcification of the coronary arteries (CAC), aortic valve (AVC), mitral valve (MVC), and thoracic aorta (TAC). We evaluated if CT variables improved the Pooled Cohort equations to Prevent HF (PCP-HF) score (an internally and externally validated model of 33,010 patients predicting 10-year risk of new-onset HF). Results: Among 6,667 …

Effects of renin-angiotensin-aldosterone-system inhibitors on coronary atherosclerotic plaques: The PARADIGM registry

Authors

Curtis Williams,Donghee Han,Hidenobu Takagi,Christopher B Fordyce,Stephanie Sellers,Philipp Blanke,Fay Y Lin,Leslee J Shaw,Sang-Eun Lee,Daniele Andreini,Mouaz H Al-Mallah,Matthew J Budoff,Filippo Cademartiri,Kavitha Chinnaiyan,Jung Hyun Choi,Edoardo Conte,Hugo Marques,Pedro de Araújo Gonçalves,Ilan Gottlieb,Martin Hadamitzky,Erica Maffei,Gianluca Pontone,Sanghoon Shin,Yong-Jin Kim,Byoung Kwon Lee,Eun Ju Chun,Ji Min Sung,Renu Virmani,Habib Samady,Peter H Stone,Daniel S Berman,Jagat Narula,Jeroen J Bax,Jonathon A Leipsic,Hyuk-Jae Chang

Journal

Atherosclerosis

Published Date

2023/10/1

Background and aimsInhibition of Renin-Angiotensin-Aldosterone-System (RAAS) has been hypothesized to improve endothelial function and reduce plaque inflammation, however, their impact on the progression of coronary atherosclerosis is unclear. We aim to study the effects of RAAS inhibitor on plaque progression and composition assessed by serial coronary CT angiography (CCTA).MethodsWe performed a prospective, multinational study consisting of a registry of patients without history of CAD, who underwent serial CCTAs. Patients using RAAS inhibitors were propensity matched to RAAS inhibitor naïve patients based on clinical and CCTA characteristics at baseline. Atherosclerotic plaques in CCTAs were quantitatively analyzed for percent atheroma volume (PAV) according to plaque composition. Interactions between RAAS inhibitor use and baseline PAV on plaque progression were assessed in the …

THU600 Coronary Calcium Scores In Medical Group Versus Individualized Dietitian-led Visits Group In An Inner-city Setting

Authors

Theodore C Friedman,Petra Duran,Matthew J Budoff,Magda Shaheen

Journal

Journal of the Endocrine Society

Published Date

2023/10

Disclosure: T.C. Friedman: None. P. Duran: None. M.J. Budoff: None. M. Shaheen: None. Obesity is highly prevalent in the U.S., particularly among ethnic minority groups. The purpose was using a randomized trial of 12-months to evaluate if coronary artery calcium (CAC) scores will decline in the medical arm compared to the dietitian-led arm and the control arm. Adult patients were recruited from LAC-DHS and randomized to medical group visit (n=58), dietitian individual visit (n=18) and control (n=50) groups. We measured the total CAC score and left anterior descending [LAD] scores using cardiac computed tomography to quantify CAC. We analyzed data for the change from baseline in the CAC scores between groups using the Kruskal Wallis test. We categorized the total CAC scores into 0-100 (no/mild risk); 101-400 (moderate risk); and > 400 (severe risk) and the LAD score into 0-99 (no/mild …

Non-calcified plaque in asymptomatic patients with zero coronary artery calcium score: A systematic review and meta-analysis

Authors

Carlson Sama,Ahmed Abdelhaleem,Dhivya Velu,Muchi Ditah Chobufo,Noah T Fongwen,Matthew J Budoff,Melissa Roberts,Sudarshan Balla,James D Mills,Tsi N Njim,Mark Greathouse,Irfan Zeb,Yasmin S Hamirani

Published Date

2023/10/9

BackgroundThere is growing interest in understanding the coronary atherosclerotic burden in asymptomatic patients with zero coronary artery calcium score (CACS). In this population, we aimed to investigate the prevalence and severity of non-calcified coronary plaques (NCP) as detected by coronary CT angiography (CCTA), and to analyze the associated clinical predictors.MethodsThis was a systematic review with meta-analysis of studies indexed in PubMed/Medline and Web of Science from inception of the database to March 31st, 2023. Using the random-effects model, separate Forest and Galbraith plots were generated for each effect size assessed. Heterogeneity was assessed using the I2 statistics whilst Funnel plots and Egger's test were used to assess for publication bias.ResultsFrom a total of 14 studies comprising 37808 patients, we approximated the pooled summary estimates for the overall …

Inflammation and immunomodulatory therapies influence the relationship between ATP-binding cassette A1 membrane transporter-mediated cholesterol efflux capacity and coronary …

Authors

George A Karpouzas,Bianca Papotti,Sarah R Ormseth,Marcella Palumbo,Elizabeth Hernandez,Maria Pia Adorni,Francesca Zimetti,Matthew J Budoff,Nicoletta Ronda

Journal

Journal of Translational Autoimmunity

Published Date

2023/12/1

Objectives High-density lipoprotein (HDL) removes cholesterol from cells in atherosclerotic lesions, a function known as cholesterol efflux capacity (CEC). ATP-binding-cassette A1 (ABCA1) membrane transporter starts cholesterol transfer from macrophages to HDL particles. In rheumatoid arthritis (RA), methotrexate and biologic disease modifying drugs (bDMARDs) are atheroprotective whereas corticosteroids and C-reactive protein (CRP) are proatherogenic. We evaluated the influence of these factors on the relationship of ABCA1-CEC with atherosclerosis and cardiovascular events. Methods Atherosclerosis was evaluated with computed tomography angiography in 140 patients with RA and repeated in 99 after 6.9±0.3 years. Events including acute coronary syndromes, stroke, cardiovascular death, claudication, revascularization, and heart failure were recorded. ABCA1-CEC was quantified in J774A. 1 murine …

Apo CIII proteoforms, plasma lipids, and cardiovascular risk in MESA

Authors

Shripad Sinari,Juraj Koska,Yueming Hu,Jeremy Furtado,Majken K Jensen,Matthew J Budoff,Dobrin Nedelkov,Robyn L McClelland,Dean Billheimer,Peter Reaven

Journal

Arteriosclerosis, thrombosis, and vascular biology

Published Date

2023/8

Background Apo CIII (apolipoprotein CIII) is an important regulator of triglyceride metabolism and was associated with cardiovascular risk in several cohorts. It is present in 4 major proteoforms, a native peptide (CIII0a), and glycosylated proteoforms with zero (CIII0b), 1 (CIII1, most abundant), or 2 (CIII2) sialic acids, which may differentially modify lipoprotein metabolism. We studied the relationships of these proteoforms with plasma lipids and cardiovascular risk. Methods Apo CIII proteoforms were measured by mass spectrometry immunoassay in baseline plasma samples of 5791 participants of Multi-Ethnic Study of Atherosclerosis, an observational community-based cohort. Standard plasma lipids were collected for up to 16 years and cardiovascular events (myocardial infarction, resuscitated cardiac arrest, or stroke) were adjudicated for up to 17 years. Results Apo CIII proteoform composition differed by age …

Vitamins to Treat Heart Disease: Can Coronary Calcium Progression Show Us the Path Forward?

Authors

Matthew Budoff

Published Date

2023/11/1

(The Aortic Valve Decalcification Trial) is discussed, which is an investigator-initiated randomized, double-blinded, placebo-controlled multicenter trial with the primary aim to investigate progression of coronary artery calcium (CAC) in persons with aortic valve calcification under the influence of vitamin K2 and vitamin D for 24 months. 1 A total of 304 (male, mean age 71 years) were randomized to supplementation with vitamin K2 (720 mg/day) and vitamin D (25 mg/day) vs placebo in a multicenter double-blinded randomized controlled trial. Overall, there was no significant change in CAC progression, although a trend appeared favoring active treatment at 24 months (D203 vs D254 AU, P= 0.089). In a subset of patients with CAC score $400, CAC progression was lower with active treatment (D288 vs D380 AU,

The quantity and quality of cardiovascular fat at mid‐life and future cognitive performance among women: The SWAN cardiovascular fat ancillary study

Authors

Meiyuzhen Qi,Imke Janssen,Emma Barinas‐Mitchell,Matthew Budoff,Maria M Brooks,Arun S Karlamangla,Carol A Derby,Chung‐Chou H Chang,Kelly J Shields,Samar R El Khoudary

Journal

Alzheimer's & Dementia

Published Date

2023/5/22

INTRODUCTION Cardiovascular fat is a novel risk factor that may link to dementia. Fat volume and radiodensity are measurements of fat quantity and quality, respectively. Importantly, high fat radiodensity could indicate healthy or adverse metabolic processes. METHODS The associations of cardiovascular fat (including epicardial, paracardial, and thoracic perivascular adipose tissue [PVAT]) quantity and quality assessed at mean age of 51 with subsequent cognitive performance measured repeatedly over 16 years of follow‐up were examined using mixed models among 531 women. RESULTS Higher thoracic PVAT volume was associated with a higher future episodic memory (β[standard error (SE)] = 0.08 [0.04], P = 0.033), while higher thoracic PVAT radiodensity with lower future episodic (β[SE] = −0.06 [0.03], P = 0.045) and working (β[SE] = −0.24 [0.08], P = 0.003) memories. The latter association is …

Coronary Artery Calcium for Allocation of Aspirin in Light of the 2022 USPSTF Guideline Recommendations: Results From the Multi-Ethnic Study of Atherosclerosis (MESA)

Authors

Dhiran Verghese,Ellen Boakye,Michael J Blaha,Sanjay Manubolu,Jairo Aldana,April Kinninger,Zeina A Dardari,Robert Cubeddu,Mazen Albaghdadi,Michael D Miedema,Joseph Yeboah,Sion Roy,Miguel Cainzos,Matthew J Budoff

Journal

Circulation

Published Date

2023/11/7

Introduction: The 2022 USPSTF guidelines issued a grade C recommendation for aspirin in patients aged 40-59 and recommended against its use in patients ≥ 60 years. We sought to assess if coronary artery calcium (CAC) would allow for personalized allocation of aspirin. Methods: Using MESA, aspirin naïve participants without high-risk bleeding features were identified. Participants were grouped by age into <60, ≥ 60 and stratified by CAC and ASCVD risk. The number needed to treat (NNT5) and number needed to harm (NNH5) was assessed by applying a 11% relative risk reduction in CVD and a 44% relative risk increase in major bleeding (2022 USPSTF meta-analysis) to the observed CVD and bleeding events from MESA Results: Of 6,814 participants, 4,506 met inclusion criteria. 2,235 were <60 years and 2,268 were ≥ 60 years. Figure-1 displays the interplay between baseline estimated ASCVD risk …

Association of apolipoproteins CI and C-II truncations with coronary heart disease and progression of coronary artery calcium: Multi-Ethnic Study of Atherosclerosis

Authors

Juraj Koska,Yueming Hu,Jeremy Furtado,Dean Billheimer,Dobrin Nedelkov,Matthew Allison,Matthew J Budoff,Robyn L McClelland,Peter Reaven

Journal

Atherosclerosis

Published Date

2023/9/1

Background and aimsHigher truncated-to-native proteoform ratios of apolipoproteins (apo) C-I (C-I’/C-I) and C-II (C-II’/C-II) are associated with less atherogenic lipid profiles. We examined prospective relationships of C-I’/C-II and C-II’/C-II with coronary heart disease (CHD) and coronary artery calcium (CAC).MethodsApoC-I and apoC-II proteoforms were measured by mass spectrometry immunoassay in 5790 MESA baseline plasma samples. CHD events (myocardial infarction, resuscitated cardiac arrest, fatal CHD, n = 434) were evaluated for up to 17 years. CAC was measured 1–4 times over 10 years for incident CAC (if baseline CAC = 0), and changes (follow-up adjusted for baseline) in CAC score and density (if baseline CAC>0).ResultsC-II’/C-II was inversely associated with CHD (n = 434 events) after adjusting for non-lipid cardiovascular risk factors (Hazard ratio: 0.89 [95% CI: 0.81–0.98] per SD), however …

Use of Cardiac Computed Tomography (CT) Imaging Biomarker Variables for the Prediction of Incident Heart Failure: Multi-Ethnic Study of Atherosclerosis

Authors

Aditya Mehta,Angelo De La Rosa,Spencer Hansen,Robyn McClelland,Alain G Bertoni,Matthew J Budoff

Journal

Circulation

Published Date

2023/11/7

Introduction: Several predictive heart failure (HF) models exist to determine incident HF. We aimed to create a model that uses cardiac CT imaging biomarkers to improve discrimination scores of incident HF. Hypothesis: Cardiac CT variables increase predictive abilities of the Pooled Cohort Equations to Prevent HF (PCP-HF) score (a validated 10-year risk of new-onset HF prediction model) in all HF, HFrEF, and HFpEF. Methods: MESA participants aged 45-84 years old and free of clinical CVD who completed a cardiac CT were included for study analysis. The outcome of interest was new-onset HF. Clinical risk factors were obtained. Cardiac CT variables analyzed included left ventricular size index (LVSi) and calcifications of coronary arteries (CAC), aortic valve (AVC), mitral valve (MVC), and thoracic aorta (TAC). Results: Among 6,667 MESA study participants who underwent cardiac CT, 426 events of new-onset …

See List of Professors in Matthew J. Budoff MD University(University of California, Los Angeles)

Matthew J. Budoff MD FAQs

What is Matthew J. Budoff MD's h-index at University of California, Los Angeles?

The h-index of Matthew J. Budoff MD has been 111 since 2020 and 159 in total.

What are Matthew J. Budoff MD's top articles?

The articles with the titles of

Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial

Closing the Last Mile Gap in Access to Multimodality Imaging in Rural Settings: Design of the Imaging Core of the Risk Underlying Rural Areas Longitudinal Study

Social disadvantage, coronary artery calcium, and their interplay in the prediction of atherosclerotic cardiovascular disease events

The Impact of Semaglutide on Liver Fat Assessed by Serial Cardiac CT scans in Patients with Type 2 Diabetes: Results from STOP Trial

Coronary artery calcium score predicts major adverse cardiovascular events in stable chest pain

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

Prediction of the development of new coronary atherosclerotic plaques with radiomics

Nontraditional Risk Markers for Incident Coronary Artery Calcium Among Persons≥ 65 Years of Age

...

are the top articles of Matthew J. Budoff MD at University of California, Los Angeles.

What are Matthew J. Budoff MD's research interests?

The research interests of Matthew J. Budoff MD are: Cardiology, Atherosclerosis, Cardiac Imaging

What is Matthew J. Budoff MD's total number of citations?

Matthew J. Budoff MD has 189,834 citations in total.

    academic-engine

    Useful Links